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ABSTRACT 
 Cellular spheroids are attractive for tissue fabrication due to having precise 
control over cell and extracellular matrix (ECM) composition, the ability for upscaled 
production and repeatability, their three-dimensional nature and the fact that spheroids 
will produce their own ECM over time. A critical process in the fabrication of complex 
tissue structures with cellular spheroids is related to their fusion and maturation. Tissue 
fusion is a self-assembly process in which two or more distinct cell populations, or 
tissues, make contact and coalesce to form a single cohesive structure. Maturation of 
tissue engineered constructs involves developing the mechanical properties and ECM 
compositions that mimic native vasculature. However, the fusion and maturation of 
spheroids and tissues composed of spheroids over time is not clearly understood. 
Therefore, developing methods to understand and accelerate the fusion and maturation of 
tissues composed of spheroids will improve upon current techniques for tissue fabrication 
with spheroids. Here, the fusion and maturation of vascular tissues mediated by magnetic 
forces was modeled using Janus Magnetic Cellular Spheroids (JMCSs). JMCSs contain 
two distinct domains: cells and extracellular iron oxide magnetic nanoparticles (MNPs). 
This separation of cells and MNPs has no adverse effects on long-term viability or 
cellular phenotype, allowing for magnetic manipulation of spheroids for building larger 
tissues. 
 Here, spheroid composition was manipulated, by varying ECM and cell contents, 
in order to study the resulting effects on JMCS fusion mediated by magnetic forces. Next, 
the influence of iron oxide MNPs on ECM production in JMCSs was studied over time. 
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Further, magnetic sheets composed of JMCSs were fabricated and their maturation 
mediated by cyclic longitudinal stretching using magnetic forces. The objective of this 
work was to determine the mechanisms associated with the fusion and maturation of 
JMCSs and tissues composed of JMCSs. The hypotheses driving this work were that 
spheroid composition dictates their fusion and that magnetic forces can be utilized to 
dynamically condition tissues composed of JMCSs for maturation. 
 Results demonstrated the critical importance of magnetic forces for promoting the 
fusion of JMCSs, when compared to JMCSs not exposed to magnetic forces. Further, 
results demonstrate the critical role of cell-cell and cell-ECM interactions for mediating 
cellular spheroid fusion over time. Results showed that the addition of iron oxide 
magnetic nanoparticles in JMCSs caused a significant increase in collagen production, 
when compared to no iron oxide controls. Quantitative results demonstrate that cyclic 
longitudinal stretching of tissue sheets mediated by magnetic forces increases the 
Young’s modulus, enhances ECM production and induces collagen fiber alignment over 
7 days, when compared to statically conditioned controls. These findings are expected to 
provide a strong theoretical and methodological foundation for the development of new 
tissue engineering technologies. 
iv 
 
DEDICATION 
 I would like to dedicate this work to my family and friends for supporting and 
loving me while I stepped out of my comfort zone to pursue my dreams. 
v 
ACKNOWLEDGEMENTS 
This work was supported by the American Heart Association Beginning Grant in 
Aid (2BGIA11720004), the South Carolina EPSCOR Grant for Exploratory Academic 
Research (2012001188), the South Carolina IDeA Networks of Biomedical Research, and 
the South Carolina Project for Organ Biofabrication. 
I would to thank my graduate research advisor, Dr. Frank Alexis, for supporting 
and guiding me through my studies. Time after time, I was amazed at how he went out of 
his way to help me succeed. Dr. Alexis kept me motivated and helped me achieve goals 
that I never thought I would be able to reach. One thing he always used to say to me was 
simply “do your best.” While the words are simple, I came to understand that they carry a 
lot of weight when he said them because he respects hard work and was willing to go the 
extra mile for me if I gave my best effort. 
I would like to express my gratitude to my research committee Dr. Rick Visconti, 
Dr. Dan Simionescu and Dr. Karen Burg for their input, guidance and support throughout 
my studies. Each committee member has hosted me in their lab or without hesitation and 
has been pivotal to helping me succeed at Clemson. I would like to thank Dr. Terri Bruce 
and Rhonda Powell at the Clemson Light Imaging Facility for their technical microscopy 
training and support of our work. I would like to thank Chad McMahan and Linda 
Jenkins for sharing their expertise in histology with me. I would also like to thank Dr. 
Roger Markwald for his guidance with regards to overcoming challenges in tissue 
engineering and biofabrication. 
vi 
 
 Next, I would like to thank my Clemson family. To be honest, it was not the 
easiest decision to leave home in New Jersey and go to graduate school at Clemson in 
South Carolina. Brandon Mattix and Thomas Moore were great mentors and made the 
transition to grad school very easy for me. I will forever be appreciative to them for 
showing me what it took to be successful at Clemson and for looking after me. I would 
like to thank all of the members of the Laboratory of Nanomedicine. I would like to thank 
Megan Casco for her support as an undergraduate and graduate research because without 
her help and the assistance, I would not have been able to graduate in less than three 
years. I want to acknowledge the undergraduate students from our lab, especially Megan 
Casco and Austin Herbst, because I really enjoyed mentoring students and it was 
sincerely fulfilling to watch them learn new things. I would like to thank the Department 
of Bioengineering for supporting me during my graduate studies, especially Maria Torres 
for providing always being available for support. 
 Finally, I would like to thank my family: Mom, Dad, Lauren, Rob for always 
being there for me, no matter what the circumstances were. My parents taught me to 
always work hard and try my best, and I will be forever grateful for the sacrifices that 
they have made for me over the years. Though Lauren is watching over me from above, 
she has strengthened my motivation to follow my dreams and always reminds me to do 
what makes me happy in life. I would like to thank Rob for providing support for my 
parents while I have been away and for always giving me the latest news in the sports 
world. I would like to thank my friends Matt, Steve and Bill for always being there to 
boost my spirits up and give me a laugh when I needed it. Finally, I would like to give a 
vii 
 
special thanks to Andi for always supporting me and understanding the stresses that come 
with life and graduate school. 
TABLE OF CONTENTS 
 
 
Page 
TITLE PAGE ........................................................................................................................... i 
ABSTRACT ............................................................................................................................ ii 
DEDICATION ........................................................................................................................ iv 
ACKNOWLEDGEMENTS ......................................................................................................... v 
LIST OF FIGURES ................................................................................................................... x 
LIST OF TABLES .................................................................................................................. xii 
Chapter 
1. BACKGROUND ............................................................................................................. 1 
 
  1.1 Vascular Tissue Engineering .......................................................................... 1 
  1.2 Scaffold-Free Tissue Fabrication Methods..................................................... 7 
  1.3 Cellular Spheroids in Tissue Engineering .................................................... 15 
  1.4 Magnetic Force Based Tissue Engineering .................................................. 25 
  1.5 Works Cited .................................................................................................. 31 
2. HISTOLOGICAL EXAMINATION OF JANUS MAGNETIC  
CELLULAR SPHEROIDS .............................................................................................. 49 
 
  2.1 Introduction .................................................................................................. 49 
  2.2 Materials & Methods .................................................................................... 51 
  2.3 Results 
   2.3.1 Individual JMCSs .......................................................................... 61 
   2.3.2 Tissues Composed of JMCSs ........................................................ 62 
  2.4 Discussion ..................................................................................................... 66 
  2.5 Conclusions .................................................................................................. 69 
  2.6 Works Cited .................................................................................................. 69 
3. FUSION OF JANUS MAGNETIC CELLULAR SPHEROIDS ................................................ 73 
 
  3.1 Introduction .................................................................................................. 73 
  3.2 Materials & Methods .................................................................................... 74 
  3.3 Results 
   3.3.1 Collagen Production in Spheroids Over Time  .............................. 81
viii  
Table of Contents (Continued) Page 
3.3.2 Factors Affecting Spheroid Fusion ............................................... 88 
3.3.3 Cellular Intermixing ...................................................................... 95 
3.3.4 Cell-Cell and Cell-ECM Interactions ............................................ 98 
3.4 Discussion .................................................................................................. 100 
3.5 Conclusions ................................................................................................ 102 
3.6 Works Cited ................................................................................................ 103 
4. MATURATION OF TISSUES COMPOSED OF JANUS MAGNETIC
CELLULAR SPHEROIDS ............................................................................................ 106 
4.1 Introduction ................................................................................................ 106 
4.2 Materials & Methods .................................................................................. 109 
4.3 Results ........................................................................................................ 115 
4.3.1 Maturation of Spheroids Over Time ........................................... 115 
4.3.2 Dynamic and Static Maturation of Tissue Sheets ....................... 120 
4.4 Discussion .................................................................................................. 131 
4.5 Conclusions ................................................................................................ 134 
4.6 Works Cited ................................................................................................ 134 
5 CONCLUSIONS ......................................................................................................... 140 
6. FUTURE RECOMMENDATIONS .................................................................................. 153
7. ACCOMPLISHMENTS ................................................................................................ 161
ix 
x 
LIST OF FIGURES 
Figure  Page 
2.1. Magnetic Force Assembly for Fabrication Tissue Rings, Sheets and Tubes ..... 55 
2.2. Hematoxylin and Eosin Stains of Cellular Spheroids Over Time ..................... 63 
2.3. Masson’s Trichrome Stains of Cellular Spheroids Over Time .......................... 64 
2.4. Histological Examination of Tissue Sheets Composed of JMCSs .................... 65 
2.5. Histological Examination of Tissue Tubes Composed of JMCSs ..................... 65 
3.1. Effect of Iron Oxide MNPs on Collagen Synthesis Within JMCSs .................. 84 
3.2. Collagen Content in Day 3 Spheroids With and Without MNPs....................... 85 
3.3. Effect of Cell Number on Collagen Synthesis Within JMCSs .......................... 87 
3.4. Spheroid Diameter with Varying Cell Numbers at Day 3 ................................. 88 
3.5. Effects of ECM on Ring Fusion and Compaction ............................................. 90 
3.6. Controlling Collagen Content During Spheroid Formation............................... 91 
3.7. Effects of ECM on Ring Fusion and Compaction ............................................. 92 
3.8. Tissue Fusion in JMCSs with Varying Collagen Content and Varying Cell 
Number Mediated by Magnetic Forces.......................................................................... 94 
3.9. Cellular Intermixing in JMCSs with Varying Collagen Content ....................... 96 
3.10. Cellular Intermixing in JMCSs with Varying Cell Number .............................. 97 
3.11. Influence of Cell-ECM and Cell-Cell Interactions on Spheroid Fusion ............ 99 
4.1. Immunohistochemistry Staining of Spheroids Over Time .............................. 119 
4.2. Processing and Post-Processing of Tissue Sheets Composed of JMCSs ......... 121 
4.3. Tissue Sheet H&E and Masson’s Trichrome Staining .................................... 123 
xi 
List of Figures (Continued) ........................................................................................ Page 
4.4. Tissue Sheet Immunohistochemistry Staining ................................................. 124 
4.5. Insoluble and Soluble Protein Content in Tissue Sheets…………………….127 
4.6. Tissue Sheet Mechanical Properties ................................................................ 128 
4.7. Collagen Fiber Alignment................................................................................ 130 
5.1. Incorporating Iron Oxide MNPs into Cellular Spheroids ................................ 141 
5.2. Magnetic Forces Mediate the Fusion of JMCSs .............................................. 143 
5.3. Varying Spheroid Composition Influences Ring Fusion Over Time............... 144 
5.4. Processing and Post-Processing of Tissues Using Magnetic Forces ............... 147 
xii 
LIST OF TABLES 
Table  Page 
1.1. Vascular Graft Technologies ............................................................................... 6 
1.2. Mechanical Properties of Native Blood Vessels .................................................. 7 
1.3. Scaffold-Free Tissue Fabrication Methods ........................................................ 15 
1.4. Magnetic Nanoparticles and Magnetic Forces in Tissue Engineering ............... 28 
2.1. Manually Processing Spheroids and Tissues Composed of Spheroids for 
Histological Examination................................................................................... 52 
2.2. Protocol for Fixing and Processing Spheroids and Tissues Composed of Janus 
Magnetic Cellular Spheroids.............................................................................. 58 
3.1. Experimental Plan for the Analysis of Collagen Production in Spheroids and 
Factors Affecting the Fusion of JMCSs ............................................................. 75 
4.1. Experimental Plan for Maturation of Tissues Composed of JMCSs ............... 109 
1 
 
CHAPTER 1 
BACKGROUND 
1.1 VASCULAR TISSUE ENGINEERING 
Cardiovascular diseases can result in numerous forms of life threatening events, 
such as coronary obstructions, spasms, rhythm disturbances, infections, acquired 
deformities, congenital malformations etc., with atherosclerosis remaining the leading 
cause of death in the United States. Although the death rates of cardiovascular diseases 
have declined, it remains a severe medical problem in the United States to address [1]. 
According to a report from the American Heart Association in 2010, more than 1/3 adults 
have some form of cardiovascular disease and the total cost for cardiovascular disease 
and stroke in the United States was $503.2 Billion [2]. Even more, a report by the 
American Heart Association in 2011 noted that each year, an estimated 785,000 
Americans will have a new coronary attack and more than 50% will have a recurrent 
attack [2]. Each year, it has been estimated that 195,000 patients will suffer from silent 
first myocardial infarctions each year. Perhaps the most worrisome statistic is that it has 
been approximated that every 25 seconds, an American will have a coronary event and in 
every minute, someone will die of one [1]. 
The main disease contributing to these grave statistics is atherosclerosis, which is 
global in distribution and is responsible for approximately half of the all deaths and 
serious morbidity in the Western world [2]. Atherosclerosis is a chronic inflammatory 
disease that is characterized by the development of intimal lesions in walls of arterial 
blood vessels that is initiated by injury to the endothelium [3]. These lesions protrude into 
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and obstruct vascular lumens and weaken the underlying media of the affected vessels. 
The main cell types of the vasculature that are involved in the disease progression are the 
endothelial cells in the intima and the smooth muscle cells in the media. The major 
consequences of atherosclerosis are myocardial infarction, cerebral infarction, aortic 
aneurysms and peripheral vascular diseases. 
 Severely narrowed and occluded atherosclerotic vessels are detectable by 
angiography and the two main treatment options are coronary artery bypass grafting 
(CABG) and percutaneous coronary intervention (PCI) [4]. During CABG, the diseased 
vessel is bypassed with an autologous graft, preferably the saphenous vein or internal 
mammary artery, to revascularize the tissue. CABG is an invasive procedure, requiring a 
median sternotomy to gain access to the heart and also a secondary surgery to harvest the 
autologous vessel for use as the graft, ultimately leading to an extended hospital stay and 
long recovery period [4]. During PCI, or angioplasty, a cardiologist guides a deflated 
balloon on a catheter from an incision in the inguinal femoral artery up to the site of 
blockage in the heart. Real-time angiography and intravascular ultrasound (IVUS) are 
used to locate the lesion and to accurately place the balloon loaded catheter and then the 
balloon is inflated to open the occluded artery [4]. Next, a stent is often deployed at the 
site of the blockage to maintain patency and blood flow. PCI is less costly and invasive to 
the patient, when compared to CABG, and patients can often go home within a few days 
and go on with their lives. Studies have shown that rates of major cardiac or 
cerebrovascular events at 12 months were significantly higher in PCI patients when 
compared to CABG patients (17.8% PCI vs. 12.4% CABG, p=0.002), due to increased 
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rate of repeat revascularization for PCI patients when compared to CABG patients 
(13.5% PCI vs. 5.9% CABG, p<0.001) [5]. However, at 12 months, the rates of death and 
myocardial infarction were similar between the two groups, while stroke was 
significantly more likely to occur with CABG (2.2% CABG vs. 0.6% PCI, p=0.003) [5]. 
Given these results, it can be seen that each procedure has a clinical need to make 
improvements for improving the life of the patient.  
 For CABG procedures, autologous replacements are the gold standard, but are not 
always readily available due to vascular disease or previous vessel harvesting [1]. They 
are from the own patient (typically the radial artery, internal mammary artery, or the 
saphenous vein), they are biologically based and have shown high long-term patency [2]. 
Complications associated with autografts include a secondary surgery site, inability to 
tailor vessel dimensions, and limited supply. Unfortunately, it is common that patient 
comorbidities prevent the use of autologous vessels. In this scenario, the surgeon has a 
few options to choose from depending on the patient and preference. An allograft is a 
vessel from another human that is decellularized and cryopreserved until needed, offering 
a readily available and biologically based replacement with a long shelf-life [2]. 
However, risks include inability to tailor matrix contents, risk of viral transmission and 
mechanical breakdown from processing. Another alternative is a xenograft, which is a 
graft taken from another species, typically porcine. These grafts are readily available, 
biologically based and have a long shelf-life. However, there is risk for immune-
rejection, the grafts often have to be modified and research has shown poor long term 
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patency [2-4]. A summary of these biological grafts with clinical status are detailed in 
Table 1.1. 
 Over 1 million procedures of coronary revascularization are performed annually 
in the United States [5]. Due to the limited supply of autologous grafts, synthetic grafts 
have been developed and are commonly used in the clinic. The two most commonly used 
materials for synthetic grafts are polyethylene terephthalate (PET, trade name is Dacron) 
and expanded polytetrafluoroethylene (ePTFE) [6]. Despite that ePTFE has been 
observed to have lower platelet adhesion and complement activation, long-term patency 
rates and performance are similar for ePTFE and Dacron [6]. Advantages of synthetic 
grafts include being able to tailor dimensions for each patient and off the shelf 
availability. W.L. Gore & Associates have been using a proprietary ePTFE blend, called 
GORE-TEX, for vascular grafts, sutures, hernia meshes and endovascular repair. 
Synthetic grafts have been used with success in large caliber vessels, but have shown 
poor performance in small diameter applications due to compliance mismatch, thrombus 
formation, infection and long term patency rates [7-9]. Autologous vein grafts usually 
have between 60-80% patency after 5 years, while synthetic grafts have 45% standard 
patency [6]. Further, these permanent prosthetic implants present the potential for a 
lifetime risk of infection and thrombus formation. A summary of synthetic grafts and 
their clinical status can be found in Table 1.1. 
 To address some of the issues associated with permanent synthetic grafts, 
biodegradable polyesters and natural polymers are being developed with or without 
recellularization of the graft (Table 1.1) [10]. Ahn and coworkers developed an 
5 
 
electrospun poly(ε-caprolactone) (PCL) and collagen scaffold, combined with a smooth 
muscle cell sheet, for a vascular graft [5]. The graft achieved high cell seeding efficiency 
and a mature smooth muscle cell layer that expressed key vascular markers, like connexin 
43, α smooth muscle actin, and myosin light chain kinase. Post-processing with a 
pulsatile bioreactor demonstrated an increase in mechanical properties, when compared 
to no conditioning (increases of 35.7% tensile strength, 47.5% elasticity and 113.2% 
elongation) [5].  
 Tissue engineered approaches have been employed to address these shortcomings 
and represent a means to fabricate functional vessel replacements capable of remodeling 
to meet physiological and mechanical demands. Tissue engineering combines the 
principles of engineering and life sciences in order to repair, restore and regenerate 
tissues and organs that mimic the functionality and mechanical properties of native 
tissues [11, 12]. In the United States, there are 121,000 people currently waiting for 
lifesaving organ transplants (kidney, liver, heart) and tissue engineering offers new hope 
and therapeutic opportunities for these patients, who might otherwise not receive the 
treatment they need [13, 14]. The classic approach to tissue engineering involves seeding 
living cells onto a solid biocompatible and eventually a biodegradable scaffold, and then 
culturing the tissue engineered construct in a bioreactor until the tissue achieves the 
desired cell density and mechanical properties (Table 1.2) for implantation [12]. For this 
review, the focus will be on scaffold-free tissue engineering technologies (Table 1.1), 
covering cell-sheet engineering, cell aggregates, bioprinting and magnetic force based 
tissue engineering strategies.  
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Table 1.1 Vascular Graft Technologies 
Approach Advantages Disadvantages Clinical Status 
Biological Grafts 
 Long Term Patency 
 Autologous Cell Sources 
 Allografts and 
Xenografts Have Off the 
Shelf Availability 
 Grafts Mimic Native 
Tissue 
 Secondary Surgery for 
Autografts with Limited 
Availbility 
 Inability to Tailor Matrix 
 Risk of Viral 
Transmission, 
Immunorejection, 
Thrombosis, and 
Mechanical Breakdown 
for Allografts 
 Risk of Immunorejection, 
Poor Long Term Patency 
and the Requirement of 
Graft Modifications for 
Xenografts 
 
 
 Autologous Grafts Are 
the Gold Standard for 
Vascular Grafts and Are 
Used if Available 
 Vein Allografts Have 
Been Used for Lower 
Extremity and Coronary 
Revascularization; 
Decelled Allografts Have 
Been Used in Animal 
Models [15, 16]  
 ProCol and ArteGraft are 
Xenografts Derived 
From Bovine Mesenteric 
Vein and Bovine Carotid 
Artery, Respectively. 
Clinical Trials Show 
That They Are Safe 
Alternatives to PTFE for 
Hemodialysis Access 
[17, 18] 
Polymeric Grafts 
 Readily Available 
 Tailored Dimensions 
 Potential for Controlled 
and Safe Degradation in 
the Body 
 Drug Delivery 
 Mechanical Mismatch 
 Poor Performance in 
Small Diameter 
Applications 
 May Require 
Endothelialization 
 W.L. Gore & Associates 
Use a Proprietary Blend 
of ePTFE for Vascular 
Grafts and Aneurism 
Repair [19, 20] 
 
Natural (Polymeric) 
Scaffolds 
 Natural Origin of 
Polymer (Elastin, 
Collagen, Fibronectin) 
Provides for Enhanced 
Cell Attachment 
 Improved Tissue 
Integration 
 Used In Combination 
with Synthetic Polymers 
 Cost to Produce 
 Purification and Isolation 
Poor Mechanical 
Properties 
 Poor Mechanical 
Properties 
 High Processing Costs  
 Potential For Immune 
Response 
Scaffold Free (Self-
Assembly) 
 Use of Autologous Cells 
 Control Over Structure 
 Purely Biological 
 Endogenous ECM 
Produced 
 Potential for Automation 
 No Harsh Processing 
 Tissue Regeneration 
 Include Cell Sheet, Cell 
Aggregate and 
Bioprinting Technologies 
 Requirement of Large 
Quantities of Autologous 
Cells 
 Time of Fabrication 
 Tend to Have Poor 
Mechanical Properties 
and Require Post-
Processing Conditioning 
 L’Heureux  and 
Coworkers  Used Cell 
Sheets and Have 
Implanted in Humans for 
Hemodialysis Access 
(Cytograft) [21] 
 Niklason and Coworkers 
Used Degradable 
Polymers With 
Autologous Endothelial 
Cell Seeding. Grafts 
Have Been Implanted in 
Primates and Are 
Awaiting Results of 
Clinical Trials 
(Humacyte) [22-24] 
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1.2 SCAFFOLD-FREE TISSUE FABRICATION METHODS 
 Scaffold-based tissue engineering strategies have demonstrated precise control 
over in-vitro microenvironments, which can provide the cues for directing the 
development of tissues. However, issues with scaffold-based tissue engineering 
approaches include degradation, mechanical mismatch, immunogenic responses and 
unforeseen long term complications. While scaffold-based tissue engineering approaches 
have seen significant advancements, scaffold-free tissue engineering approaches are 
being heavily researched because the approach aims to develop tissues by taking 
advantage of the natural self-assembly process observed in developmental biology [28]. 
Self-assembly is autonomous organization of tissue components (cells and ECM) from an 
initial state into an organized structure without external intervention [29]. Without the 
presence of an attachment surface or scaffold, cells will spontaneously aggregate and 
undergo the process of self-assembly. Tissues have the innate ability to self-assemble, 
Table 1.2. Mechanical Properties of Native Blood Vessels 
Vessel Type Burst Pressure Compliance Suture Retention Strength 
Arteries 3,196 +/- 1,264 mm Hg [25] 
11.5 +/- 3.9 %/100 mmHg 
[25] 
138 +/- 50 gmf [25] 
Veins 1680 +/- 307 mm Hg [26] 1.1 +/- 0.4 %/100 mmHg [27] 196 +/- 2 gmf [27] 
8 
 
self-organize and ultimately regenerate under the proper conditions [12, 29-35]. 
Understanding these phenomena has led to new tissue fabrication methods, which 
demonstrate high potential for clinical translation. 
 Advantages of scaffold-free technologies include no exposure of cells to harsh 
processing requirements of scaffold-based constructs, the presence of a true biomimetic 
environment with high cell communication, uninterrupted tissue remodeling, and no 
degradation byproducts (Table 1.2) [35]. Even more, if scaffold-free technologies are 
implanted in vivo, any mechanical forces will occur directly on the tissue, rather than 
having the scaffold share the load. This will result in enhanced integration and maturation 
of the tissue after implantation. One of the main limitations of scaffold-free technologies 
is the poor mechanical properties associated with self-assembled tissues due to the 
reliance on endogenous production of ECM over time [36, 37]. Post-processing methods 
are being developed to address this issue and are based on providing mechanical and 
chemical cues to the tissues that would be experienced by native tissues to accelerate the 
maturation process [36, 38, 39]. Despite these advances, there has yet to be developed a 
reliable method to produce custom ‘off the shelf’ tissues in a reproducible fashion using a 
high throughput system, especially for the fabrication of tissues with multiple cell types. 
 
Cell Sheet Approach  
Cell sheet engineering involves constructing 3D tissues by layering 2D cell sheets 
without any biodegradable alternatives for ECM [40-44].  The two main techniques use 
either thermoresponsive poly(N-iso-propylacrylamide) (PIPAAm) polymer films coated 
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on tissue culture plastic or special growth media conditions that stimulate ECM secretion, 
thereby causing the cells to create a solid tissue sheet capable of manual manipulation 
[26, 27, 41, 44]. Advantages of using cell sheet technologies are that sheets are that they 
contain endogenously produced ECM and they can be spatial oriented with multiple cell 
types to create a structurally correct tissue that can contain multiple cell types (Table 
1.3). Disadvantages of cell sheet technologies include long culture time and the need for 
post-processing techniques to enhance mechanical properties. Cell sheet technologies 
have been applied to vascular tissues, myocardial patches, corneal reconstructions, 
oesophageal, and dental tissues with demonstrated success in animal models [21, 27, 40, 
41, 43, 45, 46].      
Cytograft Tissue Engineering, founded by Nicolas L’Heureux, recently published 
the results for the first human use of an allogenic tissue engineered vascular graft for 
hemodialysis access [21]. Three allogeneic Lifeline grafts (Cytograft Tissue Engineering, 
Inc, Novato, Calif) were implanted as the brachial-axillary arteriovenous (AV) shunts for 
hemodialysis access. Results at the 6 month time point demonstrated a lack of 
degradation and immunosensitization in all patients [21]. These findings indicate that 
neither the transition to allogenic cells nor the change to a non-living graft adversely 
affected the mechanical stability of the graft. While the clinical results are promising, 
long fabrication times (6-9 months) and high autologous cell quantities required to 
produce such grafts currently mitigates their widespread use. To address this issue, both 
the fabrication times and cell quantities must be optimized prior to making such grafts 
commercially viable [47]. 
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 Humacyte, which was founded by Laura Niklason, is currently investigating the 
use of allogenic SMCs to create a cell-derived acellular scaffold. Allogenic cells are 
seeded onto a PGA scaffold and physically stimulated for two months to accelerate ECM 
secretion and induce maturation using cyclic radial strain, followed by decellularization, 
which results in a collagenous matrix. Bioengineered blood vessels were implanted as 
end-to-end arterial and aterio-venous grafts in over 25 large animal studies, with no 
evidence of hemodynamically significant intimal hyperplasia [24]. As of February 2014, 
the bioengineered blood vessels are in clinical studies for hemodialysis use [24]. The 
company aims to use this technology for vascular tissue engineering applications, as well 
as patching damaged organs and tissues.  
 
Cellular Aggregates 
 Scaffold-free cellular aggregates mimic the 3D orientation of native tissue and 
produce and secrete their own extracellular matrix (ECM) [11, 29, 34, 48]. To produce 
tissues using the aggregate method, a controlled amount of cells are dispensed and left to 
spontaneously self-assemble over time. Methods to produce cellular aggregates include 
suspension cultures, spinner flask cultures, pellet cultures and static cultures [49].  
Aggregate technologies have been successful for vascular tissues when partnered with 
non-adhesive molds, as tissue rings, toroids and tubes with measurable mechanical 
properties have been fabricated [50-54]. The technology is advantageous because it 
aggregates are biologically based, the fabrication time is short, aggregate composition 
can be controlled and the addition of molds can provide control over tissue geometry 
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(Table 1.3). Gwyther and coworkers used a circular agarose mold to fabricate SMC-
based rings with inner diameters of 2, 4, and 6 mm [55].  Results demonstrated that 
individual rings, as well as stacked rings to form tubes, could be fabricated in one to two 
weeks in static culture [53]. Mechanical testing to quantify ultimate tensile strength 
(UTS), stiffness, and toughness decreased (40% decrease in UTS in 6 mm rings) for each 
sample as culture time increased due to necrosis in the core of the ring. The development 
of a necrotic core in aggregate structures is a limitation that exists due to the lack of 
vasculature for nutrient and waste exchange. 
 Morgan’s lab reported modeling fusion kinetics of hepatocyte tissue toroids over 
time, which were fabricated from cell solutions seeded into agarose micromolds [50, 52]. 
Toroid lumen diameters were reproducible and thickness of toroids was controlled by 
varying the cell density. Their work showed that these toroids could be stacked together 
in order to undergo predictable fusion over time to form larger tissue structures, like 
blood vessels [52]. Work from their lab also quantified the forces driving the self-
assembly of toroids by measuring the upward movement of the tissues against gravity up 
a cylindrical agarose pole [51].   
 Cellular spheroids have gained much of the spotlight recently because of their 
potential to mimic tissues and organs on the micro scale [48, 49]. Spheroids with tissue-
specific functions have been fabricated for cardiac, vascular, cartilage, bone, hepatic and 
pancreatic applications, demonstrating their potentially broad impact for tissue 
fabrication [49]. Due to this, spheroids have been investigated for use in building 
vascular tissues, as well as for high throughput drug screening for pharmaceuticals. Kelm 
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and coworkers demonstrated that 3D spheroids have higher gene expressions over key 
ECM protein genes responsible for functional tissues, like collagen, fibronectin, laminin 
and matrix metallopeptidases when compared to 2D cultures [48]. Their group used 
human artery-derived fibroblasts to fabricate small diameter tissue-engineered vessels 
with spheroid building blocks. Assembled tissue constructs have been associated with 
poor mechanical properties and require post-processing maturation techniques [56-58].  
 
Bioprinting 
 Bioprinting is the automated, computer-aided, layer-by-layer deposition of cells 
and cell aggregates for building three-dimensional biological structures [59, 60]. There 
are two main techniques used, one being ink-jet printing and the other being technologies 
that utilize mechanical extruders to deposit cells and materials. Ink-jet printing is a non-
contact method that reproduces digital pattern information onto a substrate with tiny ink-
drops composed of cells, ECM, biomaterials or a combination of the three [61, 62]. Here, 
there are thermal, piezoelectric and electromagnetic approaches to create these drops on 
demand. The thermal printers work by heating the printhead to generate air bubbles 
which collapse to produce pressure pulses to eject ink drops of desired size on demand. 
The size of droplet can be controlled by the temperature, frequency of the applied current 
pulse and viscosity [63]. Piezoelectric printers work based on an actuator made from 
polycrystalline piezoelectric ceramic, which provides pressure to eject ink drops onto the 
substrate [63]. Burg and coworkers have been developed solutions to problems with 
inkjet printing and are applying their technologies to tissue test systems, breast cancer 
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models and biofabrication [64, 65]. Advantages of inkjet printing include versatility, low 
cost, and rapid nature (Table 1.3). However, concerns arise with printing high cell 
densities, high temperatures in the print heads damaging cells, and building in the ‘z’ axis 
for larger 3D structures. 
 Mechanical extruders are another bioprinting technology that place precise 
amounts of ‘bio-ink’ into supporting environments called ‘bio-paper,’ using computer 
templates [28]. Bio-ink is usually composed of cellular spheroids, where the size, shape 
and composition can be controlled. Bio-paper is a hydrogel that is typically composed of 
agarose or collagen [29]. Here, multiple cell types can be incorporated, as well as 
extracellular matrix. The spheroids are obtained by mechanically cutting uniform 
fragments that spontaneously form into spheres due to tissue liquidity. These building 
blocks can be matured by using non-adhesive molds. Next, the bio-ink can be deposited 
into its location where post-processing steps that include fusion and cell sorting cause the 
formation of organoids, or mini organs [29] . The advantage of this technology is that 
these printed bio-ink particles represent 3D tissue fragments (Table 1.3). The bio-ink can 
be deposited layer-by-layer with bio-paper to form complex 3D structures, however the 
removal of the biopaper has proven to be a challenge. Jakab and coworkers have utilized 
agarose rods and cylindrical multicellular building blocks, rather than collagen paper and 
cellular spheroids to simplify this process [29, 32]. This bioprinting technique employs 
developmental biology by allowing the tissues to self-assemble over time through fusion 
and cell sorting. The disadvantage of this method is the high cost of the printers and 
building thicker tissues that incorporate a vascular network. Organovo has developed a 
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bioprinter, called the NovoGen Bioprinting TM Platform, and is applying it to fabricate 
3D tissues for high throughput drug screening analysis [66]. Another company, called 
Nano3D Bioesciences, demonstrated that they could construct 3D tissue models of breast 
tumors. Preliminary studies using chemotherapy drugs, such as doxorubicin, suggested 
that these 3D models might better model actual tumor response to therapeutics than 2D 
cell cultures [66, 67].  
 At the moment, bioprinting is not yielding full-scale organs as imagined, but it 
has allowed researchers to gain an understanding of how tissues develop and permitted 
high-throughput screening on mini-tissues for drug screening. An interesting future 
application proposed by Boland and collaborators is the idea of a hand held bioprinter 
that can build implants and tissue replacements directly into the patient in the operating 
room [62, 63]. Another developing technology is the use of magnetic forces to print cells 
and tissues with incorporated magnetic nanoparticles [68, 69]. Regardless of the printing 
technology used, the future use of bioprinting in the clinical relies on the successful 
biofabrication of microvasculature. 
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1.3 CELLULAR SPHEROIDS IN TISSUE ENGINEERING 
 The classic approach to tissue engineering involves seeding living cells onto a 
solid biocompatible and eventually a biodegradable scaffold, and then culturing the tissue 
engineered construct in a bioreactor until the tissue achieves the desired cell density and 
mechanical properties for implantation [12]. However, new approaches that build 3D 
Table 1.3. Scaffold-Free Tissue Fabrication Methods 
Approach Technology Advantages Disadvantages 
Cell Sheets 
Layer 2D Cell Sheets to 
Create 3D Tissues Using 
Temperature Sensitive 
Culture Flasks or 
Manual Manipulation 
 Biologically Based 
 Control Over Tissue 
Spatial Orientation 
 Use of Autologous 
Cells 
 Have Been Shown 
to Yield Similar 
Mechanical 
Properties to Native 
Vessels 
 Completed Clinical 
Trials [21] 
 Require Post-
Processing 
Techniques to 
Enhance 
Mechanical 
Properties 
 Long Fabrication 
Time 
 Time Required for 
Adjacent Sheets to 
Fuse 
 Not Automated 
 Require Large 
Amounts of 
Autologous Cells 
Cellular Aggregates 
Relies On Cellular Self-
Assembly and Fusion to 
Create Larger Tissues 
 Biologically Based 
 Short Fabrication 
Time 
 Control Over Tissue 
Composition 
 Molds Provide for 
Control Over 
Geometry 
 Not Automated 
 Poor Mechanical 
Properties 
 Require Post-
Processing 
 Necrotic Core in 
Thicker Tissues 
Bioprinting 
Dispense and Pattern 
‘Bio-Ink” Into Desired 
Tissue Geometries 
Using and Automated 
‘Bioprinter’ 
 Automated 
 Biologically Based 
 Rapid Fabrication 
 Precise Control 
Over Tissue 
Composition (bio-
ink) 
 Control Over 
Spatial Orientation 
 Variable Cost 
 No Standardized 
Printer 
 Instability With 
Building in the Z-
Axis 
 Does Not Promote 
Tissue Fusion 
 Poor Mechanical 
Properties 
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tissues with a bottom up approach using cellular spheroids are offering new possibilities. 
Rapid tissue fabrication approaches using spheroids have three key bioprocessing steps 
that lead to the development of 3D tissue structures: (1) pre-processing, (2) processing, 
and (3) post-processing. 
 
Step One: Pre-processing 
 Pre-processing involves preparing the building block tissues that are used to 
ultimately fabricate the 3D tissue. Here, cellular spheroids are the building blocks being 
used as the ‘bio-ink.’ Spheroids are attractive for tissue fabrication techniques due to 
having precise control over cell and extracellular matrix (ECM) composition, the ability 
for upscaled production and repeatability, their three-dimensional nature and the fact that 
spheroids will produce their own ECM over time. Spheroids with tissue-specific 
functions have been fabricated for cardiac, vascular, cartilage, bone, hepatic and 
pancreatic applications, demonstrating their potentially broad impact for tissue 
fabrication. In addition to tissue engineering applications, spheroids are used in studying 
cancer biology and also in pharmaceuticals with high throughput toxicology and drug 
testing. 
 There are many pre-processing methods used to prepare cellular spheroids, which 
include the pellet or re-aggregation culture, spinner culture, rotating wall vessels, cell 
sheet techniques, liquid overlay, microfluidics, external forces, the hanging drop 
technique, and micro-molded hydrogels [70]. The most popular spheroid pre-processing 
methods are re-aggregation, hanging drop and micro-molds. In the re-aggregation 
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method, cells from a confluent flask are collected and centrifuged down to form a cell 
pellet in a tube [70]. This pellet can be removed from the tube, cut into fragments and 
then incubated until they form rounded spheroids. In the hanging drop technique, small 
volumes (15-30 μL) of cell suspensions are pipetted onto the lids of petri dishes [70]. The 
lid is then inverted, with the drops staying attached due to surface tension. Gravity causes 
the cell suspension to concentrate at the bottom of the droplet, forming a spheroid. Micro-
mold pre-processing utilizes computer software for rapid prototyping of ‘templates’ for 
creating micro-molds with an array of cylindrical pegs with rounded tops. These micro-
molds are then used to cast non-adhesive hydrogels into which cells can be seeded into. 
Due to the non-adhesive surface, the cells will aggregate and form a spheroid.  
 Spheroids can be fabricated with a either single or multiple cell types, which 
demonstrates the potential for fabricating many types of tissues. Even more, endothelial 
cells can be co-cultured with other cell types, like smooth muscle cells, to create 
uniluminal spheroids [71]. This is important for tissue engineering because it highlights 
the potential for using uniluminal vascular spheroids as modules for fabricating blood 
vessels. ECM proteins, like collagen or fibronectin, can be incorporated into cellular 
spheroids to promote cell-matrix interactions and provide an early structural network for 
the developing spheroids. Magnetic nanoparticles (MNPs) have also been incorporated 
into cellular spheroids to allow for the ability to pattern and align the spheroids for tissue 
assembly. This pre-processing development has allowed for tissues to be manipulated 
with physical magnetic forces at a distance in the processing step and has potential for 
being used for maturation techniques.  
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 Millions of tissue spheroids will be required for organ fabrication [69]. High 
throughput methods for spheroid fabrication have been developed for biological research, 
therapeutic testing and 3D tissue construction [72-74]. Micro-mold arrays are leading this 
thrust, with hanging drop and round-bottom well plate designs for fabricating up to 384 
spheroids per standard 96 well plate. The use of these approaches, partnered with a 
robotic dispenser increases the productivity of spheroid biofabrication [69]. After 
formation, spheroids can be stored in bio-cartridges (micropipettes) for dispensing in the 
processing step, or stored in cell culture medium for a desired incubation period. 
Preventing unwanted fusion of stored tissue spheroids will be challenge that develops 
with upscaling spheroid fabrication.  
 Ultimately, the pre-processing step allows for customization of the spheroid for 
specific applications because of the control over cell type, size, and ECM content. Given 
this precise control over composition and their versatility, spheroids are a desirable 
candidate for the pre-processing step in rapid fabrication of tissues. 
  
Step Two: Processing 
 The processing step involves dispensing the cultured spheroids into the desired 
geometry, one layer at a time. This step is critical because a bioprocessing technique is 
required to take individual spheroids and position them on a suitable substrate for tissue 
formation. In this processing step, the spheroids can be dispensed into a ‘bio-paper,’ 
which is a biocompatible hydrogel sheet that provides a non-adhesive surface for the 
spheroids to be printed on [11, 59, 75]. The bio-paper has been mimicked after the natural 
19 
 
ECM and contains the minimal composition for cell attachment, growth and maintaining 
tissue liquidity for permitting fusion of the spheroids. Crosslinked agarose and gelatin 
have been shown to function well as the bio-paper, as both provide the required non-
adhesive surface for the tissues to be printed onto [59]. The bio-paper can also be molded 
into desired geometries with a peg and circular well, which allows tubular structures to be 
formed. Standard non-treated, non-adhesive polystyrene plates are used for culturing 
spheroids long term, as well as assembling tissues [76-78]. Ideally, the bio-paper should 
mimic the stiffness of the tissue being fabricated.  
 In order to dispense spheroids for patterning and alignment, robotic pipette 
dispensers, like the EpMotion-5070 (Eppendorf), have been developed [69]. 
Developments in rapid prototyping technologies has allowed for robotic bioprinters to be 
able to continuously dispense spheroids using x-y-z precise robotic position, automated 
spheroid dispensers, and computer based software [69]. While these devices have been 
shown to successfully pattern the spheroids, these devices have issues when building 
tissues up in the z direction without the use of a mold. Bioprinters are usually custom 
built, based on the need of the laboratory, and have not yet been standardized in industry. 
Given this, as lot of tissue assembly is ‘done by hand’, meaning the spheroids are 
dispensed into the biopaper or molds in a non-automated fashion using a pipette. To 
‘build’ tissues, spheroids can be dispensed on top of each other in a layer by layer fashion 
on a biopaper using a bioprinter, spheroids can be dispensed into molds and plates with 
predefined geometries, or magnetically labeled spheroids can be patterned and aligned 
using magnetic fields [69, 76-78]. 
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 After the spheroids have been patterned and aligned into the desired geometry, 
passive contacts from cell-cell and cell-matrix interactions will cause the spheroids to 
fuse together to reduce configurational energy. Fusion occurs when adjacent spheroids 
make contact and coalesce into a cohesive tissue, and this is an essential process for 
tissue maturation. Macroscopically, individual spheroids should no longer be visualized 
in a fused tissue. While bioprinters and micro-mold designs create passive contact 
between spheroids, they do nothing to accelerate spheroid fusion, which is critical for 
tissues manipulation during maturation. Recently, magnetic fields have been used as a 
physical force to accelerate the fusion process with active contacts by increasing cell-cell 
and cell-matrix interactions in magnetic cellular spheroids [78]. Mattix and coworkers 
demonstrated that magnetic cellular spheroids whose fusion was mediated by magnetic 
forces produced a more cohesive and homogenous tissue at earlier time points, when 
compared to control spheroids without magnetic forces. The use of magnetic forces for 
accelerating the fusion of magnetic cellular spheroids is a critical improvement because 
these fused tissues can be introduced into post-processing methods for maturation at 
earlier time points than previously. 
 Step Three: Post-processing 
 The post-processing step involves using bioprocessing techniques for promoting 
tissue maturation. Tissues fabricated with spheroids are often associated with poor 
mechanical properties. Increasing the synthesis, deposition, cross-linking and assembly of 
ECM is critical for accelerating the maturation of fused tissues because it develops the 
dense structural network that translates to tissue strength [11, 75]. 
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 To accelerate the maturation of fused tissues, bioreactors have been designed to 
simulate in vivo conditions and provide the necessary chemical and mechanical cues 
experienced by native tissues. Some key characteristics of bioreactors include being able 
to: (1) control the environment during mechanical stimulation; (2) stimulate multiple 
constructs with identical or individual waveforms; (3) deliver precise displacements, 
including those that mimic in vivo activities of daily living; and (4) adjust displacement 
patterns based on reaction loads and biological activity [79]. Bioreactor types include 
spinner flask bioreactors for cell seeding on 3D scaffolds, rotating wall vessels for 
providing a dynamic culture environment with low shear and high mass transfer, hollow-
fiber bioreactors for enhancing mass transfer during culture of highly metabolic and 
sensitive cell types, direct perfusion bioreactors for to have medium or cell solutions flow 
throughout a tissue or scaffold and bioreactors that provide controlled mechanical forces 
to the tissue [80].   
 Utilizing controlled mechanical forces has become the most popular for rapid 
fabrication techniques because mechanical methods offer the ability to deliver 
mechanical cues that tissues experience in the physiological setting. Mechanical forces 
used to induce maturation include pulsatile radial strain, longitudinal stretch, pulsatile 
flow, and compression [56, 80-84]. These forces can be precisely controlled and 
generated using software, like LABVIEW, paired with stepper motors, pumps and 
actuators. Mechanistic variables include frequency, magnitude, time per day of 
stimulation, and total days of stimulation. Research has shown that these mechanical 
methods have successfully accelerated tissue maturation in terms of ECM deposition and 
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increased mechanical properties for tissues based on cell sheet technologies and collagen 
gel tissue constructs [56, 81, 83]. Cyclic radial stretching and pulsatile flow have been 
shown to enhance ECM production (collagen and elastin) and enhance mechanical 
properties of tissue engineered blood vessels, but the parameters for optimal maturation 
(frequency, magnitude, time of stimulation) have not been defined [56, 57, 82, 83, 85]. 
Both static and dynamic longitudinal stretch of tissue sheets have accelerated 
extracellular matrix deposition and rapidly improve mechanical properties, both of which 
are critical for the development of a suitable tissue engineered replacements [81, 86]. 
 Recently, magnetic forces have been investigated for mechanical conditioning 
with ‘action at a distance.’ By taking advantage of cells and ECM tagged with MNPs, 
RT-PCR results showed that dynamic magnetic forces (1 hr/day, 1 wk, 1 Hz) led to 
upregulation of osteocalcin, osteopontin and alkaline phosphatase in human bone cells, 
when compared to controls [87]. Using magnetic forces for maturation offer several 
advantages: (1) precise control of physical stresses through variation of the magnetic 
force; (2) the MNPs are remotely coupled to a magnet array with no components 
connected inside the bioreactor, reducing potential contaminations; (3) magnetic arrays 
are scalable and present the opportunity to apply varying load profiles via particles and 
magnets of differing magnetic properties [87]. 
 Despite advances in tissue maturation, standardized methods have not been 
developed for large scale applications and a challenge remains for understanding what 
mechanisms drive in vitro tissue maturation. 
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Current Challenges in Pre-processing, Processing and Post-Processing of Spheroids 
 Poor mechanical properties, a lack of understanding fusion and maturation 
mechanisms, and the absence of engineered vascular networks creates uncertainty for 
fabricating viable and functional engineered tissues and organs. While long term viability 
of individual spheroids has been confirmed up to 7 weeks, the long term viability of 
larger tissues composed of spheroids is of concern due to the need for a method of 
nutrient and waste exchange with increasing tissue depth [78]. The ideal cell number and 
ECM content of spheroids for rapid tissue fabrication has not been elucidated and will 
likely be dependent on the application. A typical tissue engineered construct requires 10
7
 
to 10
9
 cells, which means upscaling and automating spheroid production is required to be 
able to fabricate tissues and organs [11, 69].  
 Understanding and accelerating the fusion of spheroids is essential for the success 
of tissue fabrication. High throughput testing of maturogenic factors on fusing spheroids, 
as well as studying the influences of cell number and ECM content on fusing spheroids is 
providing quantitative data for understanding the mechanisms of this maturation process 
[39]. Work by Hajdu and coworkers demonstrated that tissue spheroids incubated with 
maturogenic factors, TGFβ1 and serotonin, were more cohesive than control spheroids 
and on average were enveloped 40% by untreated spheroids, versus 10% by control 
spheroids [39]. Results also showed that these maturogenic factors had increased levels 
of collagen production as exhibited by increased immunofluorescent levels of Hsp47, a 
known intracellular chaperone of collagen types I-IV [39].  
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 Magnetic forces have successfully been used to align magnetic cellular spheroids 
and accelerate their fusion by promoting active contacts between cells [76-78]. This 
technology has promise in developing technologies because physical forces generated by 
the magnetic field are able induce maturation without coming into contact with the tissue.  
 Currently, mechanical post-processing methods for maturing fused spheroids are 
in the early stages of development. Obtaining measurable mechanical properties of fusing 
and maturing tissues over time will lend insight for optimizing post-processing 
maturation techniques. Ideally, engineered tissues should contain the necessary cell types, 
ECM content and mechanical properties that would be required for functionality in vivo. 
Rapidly fabricated tissues should be available for use after maturation, or be stored long 
term for future needs. Preventing the unwanted fusion of spheroids stored for long term 
use must also be addressed.  
 The pre-processing, processing and post-processing steps in rapid tissue 
fabrication with spheroids have limitations that require improvements. Upscaled spheroid 
production, accelerating the fusion of spheroids with magnetic forces and improvements 
in bioreactor design give promise for using spheroids in rapid tissue fabrication. These 
emerging bioprocessing techniques must meet regulatory requirements that will emerge 
from their development to ensure their safety and efficacy in clinical applications. The 
lack of an engineered vascular network is the limiting factor in building tissues and 
organs with spheroids and must be addressed moving forward. 
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1.4 MAGNETIC FORCE BASED TISSUE ENGINEERING 
 Magnetic nanoparticles (MNPs) are now being increasingly used in biomedical 
applications, with some FDA approved iron oxide MNP formulations used to treat iron 
deficiency (Feraheme) or as MRI contrast agents (Feridex) MNPs have been investigated 
in tissue engineering applications for in vivo cell tracking, in vivo monitoring of 
transplanted tissues, cell and tissue patterning, and tissue maturation [88-97]. The 
prolonged presence of these nanomaterials within biological systems remains a concern 
due to potential adverse effects on cells, which is caused by toxicity and undesired 
changes in cell phenotype [90, 98-100]. Though the surface functionalization or coating 
of MNPs in oleates,
 
dextran,
 
or polymers can improve MNP biocompatibility, they do not 
control the MNP degradation [101-106]. Accelerating the degradation of nanomaterials 
within biological systems is expected to reduce the potential adverse effects in the tissue. 
A variety of different chemicals, primarily organic acids, have been investigated to 
accelerate the degradation of iron oxide MNPs [107-112]. Mattix and coworkers reported 
the precise control of iron oxide MNP degradation via MNP encapsulation within 
biodegradable polymers for tissue engineering applications [77]. Similar to biodegradable 
polymeric scaffolds, the ideal nanomaterial will remain stable for a sufficient amount of 
time to accomplish its desired task, and then rapidly degrade once that task is completed.  
 
Magnetic Nanoparticles in Tissue Engineering 
 Magnetic assembly is attractive for tissue engineering applications because it 
allows for manipulation and patterning from a distance with magnetic fields [113]. A 
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variety of methods that utilize internalization of MNPs into cells have been investigated 
to integrate MNPs with tissue engineering, including MNP conjugation/binding to the 
cell [89, 92, 93], cellular internalization [98, 114-116], and mixing MNPs within the 
ECM [88, 114, 117].  Practically speaking, having dark magnetic nanoparticles make 
tissue visualization and imaging easier. Cells labeled with iron oxide MNPs have been 
transplanted into rats and tracked over time using MRI (Table 1.4) [118]. In vitro studies 
have shown that labeled cells partnered with magnetic forces enhanced cell seeding on 
tissue engineered constructs [119]. Further, magnetic forces have been used to improve 
upon current scaffolding technologies, as Bock and coworkers have developed a 
magnetic scaffold to which growth factors or other biologically active molecules bound 
to magnetic particles can be delivered on demand by means of an externally applied 
uniform magnetic field [120]. However, all of these approaches are limited to short term 
studies due to adverse effects related to MNP internalization [88-90, 116, 121] into cells. 
One particular concern for vascular tissue applications is the unwanted activation of 
endothelial and smooth muscle cells by nanoparticles over time [119]. This can lead to 
downstream intimal hyperplasia, which compromises vessel patency. 
 A novel method to incorporate iron oxide magnetic nanoparticles into cellular 
spheroids was developed, called the Janus method, and this technology is innovative 
because upon spheroid fabrication, two separate domains are created: cells and MNPs 
[37, 76-78, 122]. The limited interaction between cells and MNPs allows high viability 
and phenotypic expression to be maintained over time, which is essential for tissue 
engineering applications. MNPs can also be incorporated into spheroids using the 
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dispersed and uptake methods. The dispersed method distributes MNPs throughout the 
spheroid, while uptake spheroids are fabricated from cells that have previously 
internalized MNPs [78]. Bratt-Leal and coworkers developed a method to entrap MNPs 
into the extracellular space of stem cell spheroids using PDMS microwells and 
centrifugation [123]. Advantages of incorporating MNPs into tissue spheroids include 
manipulating and aligning spheroids into desired patterns for tissue engineering 
applications without adverse effects on viability or phenotype (Table 1.4) [36, 37, 76, 
113, 122, 124]. Further, tissues composed of magnetic cellular spheroids can be matured 
using magnetic forces during post-processing steps. Spheroids composed MNPs have 
been used to fabricate a tissue tube composed of endothelial cells, smooth muscle cells 
and fibroblasts with controlled spatial orientation as a proof of concept for engineered 
vasculature [78]. Recently, Olsen and coworkers studied the influences varying spheroid 
composition on the fusion of vascular spheroids mediated by magnetic forces and also 
demonstrated that spheroids containing iron oxide magnetic nanoparticles produce more 
collagen over time when compared to no iron oxide controls [37]. Concerns with this 
technology include the development of a necrotic core due to diffusion limitations, 
understanding the influences of MNPs on ECM production, the requirement of large 
quantities of cells and the need for post-processing maturation of tissues composed of 
spheroids because of poor mechanical properties [2, 37].  
 Magnetic cellular sheets have been fabricated and contain cells, ECM and MNPs 
[91, 125]. Typically, MNPs are incorporated into the cell sheets using uptake and 
internalization of the particles. The technology is advantageous because 2D sheets can be 
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Table 1.4. Magnetic Nanoparticles and Magnetic Forces in Tissue Engineering 
layered to form 3D structures, magnetic forces can be used to wrap the sheets around 
tubes for vascular applications, and these tissues can potentially be stimulated using 
magnetic forces for maturation (Table 1.4). Ito and coworkers used this approach to wrap 
a magnetic cell sheet around a magnetic mandrel and assembled multicellular tissue tubes 
[126].  However, this method induced internalization of MNPs into cells prior to cell 
sheet assembly and will likely encounter adverse effects related to MNP uptake in long-
term applications [98, 127].  
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Post-Processing Maturation Using Magnetic Forces 
 Magnetic forces are now being employed to induce maturation of MNP labeled 
tissues by applying mechanical forces directly to the particles contained within the cells 
and tissues. This technology is advantageous because tissues can be stimulated with 
action at a distance, with controlled frequency, magnitude, strength of field and time of 
stimulation (Table 1.4) [87, 128, 129]. Further, the technology can be automated, which 
can allow for multiple load profiles to be tested using this scalable technology. To 
improve upon this developing technology, there needs to be a deeper understanding on 
the influence of MNP stimulation by magnetic forces in tissues over time, the optimal 
magnetic force conditions need to be developed for tissues of interest, there needs to be 
some sort of standardized system and finally, with any developing technology, cost for 
development is a concern [129]. 
 Thus far, magnetic forces have been used to mature bone constructs [130-132]. 
Magnetic particle-labeled human bone marrow stromal cells (HBMSCs) encapsulated 
into alginate chitosan capsules were exposed to magnetic forces both in vitro and in vivo 
intermittently for 21 days [130]. A pulse magnetic conditioning bioreactor was used with 
1 Hz frequency and 1 hour of stimulation per day. After 21 days the encapsulated, 
magnetic particle-labeled HBMSCs in vivo were viable as evidenced by extensive cell 
tracker green fluorescence. The mechanical stimulation of HBMSCs labeled with TREK-
1 magnetic nanoparticle receptors enhanced expression of type-1 collagen in vitro with 
increases in proteoglycan matrix, core binding factor alpha1 (Cbfa1) and collagen 
synthesis, and extracellular matrix production and elevated the expressionof type-1 and 
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type-2 collagen in vivo. Additionally, the magnetically remote stimulation of HBMSCs 
labeled with magnetic nanoparticle arginine–glycine–aspartic acid considerably enhanced 
proteoglycan and collagen synthesis and extracellular matrix production and elevated the 
expression of type-1 and type-2 collagen in vivo and in vitro [130]. 
 Another interesting application of magnetic forces for maturation purposes is the 
delivery of biological agents on demand. Zhao and coworkers developed a macroporous 
ferrogel scaffold that can be remotely controlled by a magnetic field to deliver various 
biological agents on demand [133, 134]. The active porous scaffold gives a large 
deformation and volume change of over 70% under a moderate magnetic field. Under 
applied magnetic fields, the macroporous ferrogel gave large and prompt deformation, 
causing water flow through the interconnected pores. The resulting deformation and 
water convection was shown to trigger and enhance the release of biological agents in a 
mouse model [133]. 
 Sapir and coworkers investigated the potential use of magnetic forces to develop 
vessel like structures in alginate scaffolds [135]. Magnetite-impregnated alginate 
scaffolds seeded with bovine aortic endothelial cells were stimulated during the first 7 
days out of a total 14 day experimental course and showed significantly elevated 
metabolic activity during the stimulation period. Samples were stimulated using an 
externally applied alternating magnetic field with a frequency of 40 Hz and strength of 
10-15 Oe. Expression of proliferating cell nuclear antigen (PCNA) indicated that 
magnetically stimulated cells had a lower proliferation index as compared to the non-
stimulated cells. This suggests that the elevated metabolic activity could instead be 
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related to cell migration and re-organization. Immunostaining and confocal microscopy 
analyses supported this observation showing that on day 14 in magnetically stimulated 
scaffolds without supplementation of any growth factors, cellular vessel-like (loop) 
structures, known as indicators of vasculogenesis and angiogenesis were formed as 
compared to cell sheets or aggregates observed in the non-stimulated (control) scaffolds 
[135]. 
 As it can be seen, magnetic forces are being increasingly used in tissue 
engineering applications due to the unique capabilities of the technology. Exciting 
aspects are that no special mediums, scaffolds, matrices or molds are required for 
magnetic forces based tissue engineering. The technology is simple, flexible and has been 
shown promising results for drug screening, tissue fabrication, stem cell research and 
regenerative medicine. Ultimately, magnetic force based tissue engineering will have to 
be compared side-by-side with other tissue fabrication methods to determine its true 
value for future use. 
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CHAPTER 2 
HISTOLOGICAL EXAMINATION OF JANUS MAGNETIC CELLULAR SPHEROIDS 
2.1 INTRODUCTION 
 Tissue engineering uses knowledge of biology, material science, biochemistry, 
engineering and physiological systems to replace or repair damaged, diseased or lost 
tissues in the human body with functional tissue that mimics native tissue. One of the 
biggest challenges in the field of tissue engineering is the in vitro fabrication of 
functional tissue engineered constructs with high cell density, high cell viability and an 
extracellular matrix (ECM) network that mimics native tissue. Cellular spheroids are 
composed of cells and the extracellular matrix (ECM) that they produce, and are 
extensively used in basic science, developmental biology, cancer biology, tissue 
engineering, drug discovery and toxicity testing. When compared to two dimensional in 
vitro cell cultures, three dimensional cell cultures are being investigated as building 
blocks for scaffold-free tissue engineering applications due to their ability to mimic the 
native cellular and ECM environment of natural tissues [36]. More recently, spheroids are 
being developed for use as tissue building blocks for rapid tissue fabrication in 
regenerative medicine. Achieving high cell densities, developing a network of ECM and 
maintaining high cell viability are necessary for the fabrication of functional tissue 
engineered constructs. 
 Spheroids can be fabricated with one cell type, or co-cultured with other cell 
types, which is desirable for fabricating tissue types with varying complexities and 
functionalities[30, 59]. Tissue assembly and fabrication methods include 3D printing, cell 
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sheet techniques, and patterned molds [11, 26, 29, 32, 62, 136]. These methods assemble 
the spheroids or cells into a desired position through passive contact, but do not 
encourage active contact mediated by forces to promote fusion of the tissue over time. 
This can cause issues with tissue inhomogeneity, geometrical defects and increases in 
fabrication time. Our lab has developed the Janus magnetic cellular spheroid (JMCS) 
structure to safely incorporate iron oxide magnetic nanoparticles (MNPs) into cellular 
spheroids [2, 76-78]. This method allows for spatial control over MNPs to form two 
distinct domains: cells and extracellular matrix. Safely incorporating MNPs allows for 
utilizing magnetic forces at a distance to pattern JMCSs into desired geometries for 
building larger, more complex tissue constructs such as rings, spheroid sheets and tubes 
for various tissue engineering applications[78]. 
 With an increasing use of spheroids in tissue engineering applications, it is critical 
to understand and visualize cellular and structural changes in developing spheroids and 
tissues composed of spheroids over time. While histological stains have been developed 
and standardized to meet these needs, a challenge remains in the preparation of cellular 
spheroids for histological sectioning and examination. The size of spheroids used for 
tissue building blocks ranges from 200-500 µm and this depends on the cell number used 
[70]. The small size of spheroids presents challenging methodologies for histological 
preparation. Conventional histological processors are not recommended to process 
spheroid anatomic qualities and preserve morphological properties. Preparing research 
samples with conventional standard processing methods can increase opportunity for 
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delicate samples to dissipate or increase degradation. Manually processing samples 
enhances spheroid survival and continuation of research.  
 Further, it is critical to understand and visualize the fusion and maturation of 
tissues composed of JMCSs over time. To understand these mechanisms, studies must 
include analyzing phenotypic expression, visualizing the spatial orientation and viability 
of cells, studying extracellular matrix organization and localizing iron oxide magnetic 
nanoparticles throughout the developing tissues over time. Tissue stains, such as the 
hemotoxylin and eosin (H&E) stain, the Masson’s Trichrome stain, the Verhoeff-Van 
Gieson stain, Turnbull’s Blue Reaction stain, and immunohistochemical stains have been 
developed for these purposes. While histological examination allows for analysis of the 
tissues composed of spheroids, preparing and processing these tissues for staining and 
analysis is challenging. It is not recommended to use conventional histological processors 
or standard processing methods, due to the delicacy of the samples, which makes it 
necessary to use manual processing to increase the survival of the samples and preserve 
tissue morphology. Here, we report the techniques developed in our lab used for 
preparation of spheroids and tissues composed of spheroids for manual histological 
examination. 
 
2.2 MATERIALS & METHODS 
 An overview of experimental procedures, parameters, and objectives can be found 
in Table 2.1. 
 
52 
 
Table 2.1. Manually Processing Spheroids and Tissues Composed of Spheroids for 
Histological Examination. A method was developed to manually process spheroids and 
tissues composed of spheroids for histological examination, while preserving tissue 
morphology. Processed samples were sectioned and stained using a Hemotoxylin and 
Eosin stain, Masson’s Trichrome stain, LIVE/DEAD stain and immunofluorescence 
staining. 
 
 
Cell Culture 
 Primary rat aortic smooth muscle cells (SMCs) were used for all studies.  All cells 
were cultured in monolayer cultures at 37 °C and 5% of CO2 until spheroid assembly. 
SMCs were cultured using Dulbeco’s Modified Eagle Medium: F-12 (ATCC, 1:1, 
DMEM: F-12) supplemented with 10% fetal bovine serum (Atlanta Biologics, Miami, 
Florida) and 1% penicillin-streptomycin-amphotericin (MediaTech, Inc., Manassas, 
Virginia).  
 
Spheroid Assembly 
 Spheroids were prepared using a method developed in our lab and previously 
described [36, 37, 76-78]. Our lab developed the Janus structure of magnetic cellular 
spheroids (JMCS), which provides spatial control of MNPs to form two distinct domains: 
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cells and extracellular MNPs [78]. No Iron Oxide (NIO) spheroids are fabricated without 
iron oxide MNPs. Equal volumes of solutions containing suspended iron oxide MNPs 
(Fe3O4, 20-30 nm, SkySpring Nanomaterials, Inc., Houston, Texas), collagen (Bovine, 
Type I, Life Technologies, Carlsbad, California), and cells in cell culture media were 
combined and dispensed to form spheroids. Collagen, Type I was prepared according to 
the manufacturer recommendations and kept on ice prior to use for all samples. 
Formulations calling for no iron oxide were replaced with an equal volume of media. 
 
Fabrication of Tissue Rings 
 Rings composed of JMCSs were assembled using ring magnets (2 mm outer 
diameter, 1 mm inner diameter, 1 mm thick, vendor calculated pull force = 0.16 lbs, 
SuperMagnetMan Inc., Alabama, USA) (Figure 2.1A). The magnets were attached to the 
bottom of glass chamber slides containing cover glass bottoms. The wells were filled 
with cell culture media and 25 individual JMCSs of the same formulation (same cell 
number, ECM concentration and iron oxide MNP concentration) were carefully patterned 
in a monolayer around the magnetic ring using pipette tips. The rings were incubated at 
37°C and 5% CO2 for 48 hours to allow fusion to occur, after which the magnets were 
removed. This was found to be the minimum time required to manipulate the rings, while 
keeping them intact.  
Fabrication of Tissue Sheets 
 Sheets composed of JMCSs were assembled using a strip of magnets (2.5 mm 
outer diameter, 5 mm length, K&J Magnetics, Inc., Pennsylvania, USA) (Figure 2.1B). 
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Five magnets were attached to the underside of a 6 well plate (Greiner Bio-One, North 
Carolina, USA) and a glass cover slip (micro cover glass 22x30 mm, VWR, 
Pennsylvania, USA) was positioned directly over the magnets within the well plate to 
prevent spheroid adherence to the well plate. The wells were filled with cell culture 
media and 1,000 JMCSs were carefully aligned on the coverslip using a pipette tip and 
incubated at 37°C and 5% CO2 for 3 days to allow fusion to occur. Three days was found 
to be the minimum time required to manipulate the tissue sheets while preserving 
morphology. To remove the tissue sheets, a sterile pipette tip was used to gently scrape 
the sample off the surface of the glass so that it could be collected for processing. 
 
Fabrication of Tissue Tubes 
 
 After 3 days, fused tissue sheets composed of JMCSs on glass cover slips were 
removed from the 6 well plate. Next, fused tissue sheets were wrapped around a silicone 
tube (5 mm outer diameter, 2.5 mm inner diameter, Cole-Parmer, Illinois, USA) 
containing a magnet (2.5 mm diameter, 5 mm length, pull force = 1.8 lbs, 
SuperMagnetMan Inc., Alabama, USA) within its lumen to effectively wrap the sheets 
around the tube (Figure 2.1C). To avoid oxidation of the magnet by culture media, the 
ends of the silicone tube were plugged with silicone rubber. Samples were incubated in 
culture medium at 37˚C and 5% CO2 for 7 additional days. This was found to be the 
minimum time required to manipulate the tissue tubes without them breaking apart upon 
removal of the sample from the silicone tube.
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Figure 2.1. Magnetic Force Assembly for Fabrication of Tissue Rings, Sheets and 
Tubes. To study the fusion of JMCSs, spheroids were magnetically patterned into various 
geometries to represent various tissue engineering applications. A schematic for the 
magnetic patterning of tissue rings (Figure 2.1A), tissue sheets (Figure 2.1B) and tissue 
tubes (Figure 2.1C) is shown with pictures of each respective tissue after fabrication. 
(Scale = 500 μm). 
 
Spheroid Fixation, Processing, Embedding and Sectioning 
 
 Spheroids were collected and individually placed into 0.65 mL conical tubes with 
150 µL of Z-Fix (buffered zinc formalin, Anatech Ltd., Battle Creek, Michigan) for 
overnight fixation. Samples were allowed to settle to the bottom of tubes via gravity. The 
following day, the Z-fix was removed and the spheroid samples were dehydrated using a 
series of ethanol and xylene incubations (Table 2.2). For ethanol solutions, deionized and 
distilled water was used for dilutions. Our lab works with spheroids that incorporate iron 
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oxide MNPs, making visualization of the spheroids easier. However, spheroids composed 
of just cells and ECM are often difficult to visualize because of the white/clear color of 
cells and ECM. After the second 100% ethanol step, spheroids were transferred using a 
pipette to individual embedding molds filled with xylene. This step is critical because 
once the spheroid is in xylene, visibility of spheroids with just cells and ECM becomes 
very poor, so this ensures that these samples makes it to the embedding molds. After 
incubating the samples in xylene, this solution is carefully removed using a pipette 
(without removing the cellular spheroid) and replaced with molten paraffin for overnight 
infiltration of the samples. Samples were incubated with molten paraffin overnight at 
56˚C. 
 The next day, the embedding molds were filled with molten paraffin and the 
cellular spheroids were oriented to the center of the mold for ease of sectioning. Each 
embedding mold containing a spheroid sample was then covered with a numbered 
embedding block holder and placed on a cold plate at -4˚C for at least 1 hour prior to 
removal of the embedding mold. 5 µm thick microtome cuts of spheroid samples were 
taken. Microtome cuts were floated on a water bath and placed on a glass histology slide. 
For further review at both macroscopic and microscopic levels, each slide was visually 
examined grossly and under a microscope to ensure that spheroids were fully intact 
(analyzed for tears, rips or sample irregularities). The slides containing the samples were 
incubated overnight in a 65˚C oven to dry and remove excess paraffin. 
 
Tissue Fixation, Processing, Embedding and Sectioning 
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 Ring tissues composed of JMCSs were left in their well plates and the cell culture 
media was removed and replaced with Z-Fix for overnight fixation (buffered zinc 
formalin, Anatech Ltd., Missouri, USA) for overnight fixation. Tissue sheets were left in 
their well plates and the cell culture media was removed and replaced with Z-Fix for 
overnight fixation. The tissues were left in their respective well plates and the magnets 
were left in place for overnight fixation to prevent any issues that could arise from 
handling the tissues and to preserve tissue morphology. Tube tissues were left on the 
silicone mandrel and placed into a glass vial to be submerged in Z-Fix for overnight 
fixation. The tissue was left wrapped around the silicone mandrel and the magnet left in 
the lumen for overnight fixation in order to preserve tissue morphology. 
 After overnight fixation, the Z-Fix was removed and the tissue samples were 
dehydrated using a series of ethanol and xylene incubations (Table 2.2) [137]. 
Immediately prior to the first ethanol incubation, the tissue tube was removed from the 
silicone mandrel. Given that our lab has done extensive histological examination of 
spheroids, a protocol was developed for preparing and processing these individual 
spheroids. However, since the tissue rings, tissue sheets and tissue tubes are larger, more 
complex and composed of many spheroids, the times for the ethanol incubations were 
doubled to ensure proper infiltration. For ethanol solutions, deionized and distilled water 
were used for dilutions. The times selected for incubation were chosen in accordance 
with literature values with automated and manual processing [138]. The times used for 
incubation are also comparable to what automated tissue processing programs regularly 
use (SAKURA Tissue TEK VIP) for standard tissue processing. After incubation in 
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xylene, the solution was removed and replaced with molten paraffin (Surgipath EM-400, 
56°C, Leica, Illinois, USA) using a Tissue-Tek TEC Tissue Embedding Console System 
(Sakura, California, USA). Samples submerged in molten paraffin were placed in one of 
the thermal chambers of the embedding console for overnight infiltration of paraffin at 
60˚C.  
  
 
 After overnight incubation in molten paraffin, tissue samples were transferred to 
appropriately sized embedding molds filled with molten paraffin. Here, care was taken to 
properly orient the tissues in the center of the mold for ease of sectioning. The embedding 
molds were each covered with a numbered embedding block holder and placed on a cold 
plate at -4°C for at least 1 hour. Following, the molds were removed and embedded tissue 
blocks were placed in an ice water bath for 10 minutes in order to rehydrate the tissue 
samples for ease of sectioning. A microtome was used to cut 5 μm thin sections from the 
tissue samples. These sections were suspended on the surface of a heated deionized water 
Step Reagents Time for Spheroids Time for Tissues 
1 Z-Fix Overnight Overnight 
2 70% Ethanol 15 minutes 30 minutes 
3 80% Ethanol 15 minutes 30 minutes 
4 95% Ethanol 15 minutes 30 minutes 
5 95% Ethanol 15 minutes 30 minutes 
6 100% Ethanol 15 minutes 30 minutes 
7 100% Ethanol 15 minutes 30 minutes 
8 Xylene 10 minutes 15 minutes 
9 Molten Paraffin Overnight Overnight 
Table 2.2. Protocol for Fixing and Processing Spheroids and Tissues Composed of Janus 
Magnetic Cellular Spheroids 
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bath (44˚C) and placed on a silanized glass histology slides (Adhesive Coated Slides, 
New Silane White Frosted, Newcomer Supply, Wisconsin, USA), due to the delicacy of 
the tissue samples[139]. Each slide was visually examined under a microscope to see if 
the sample was observed and to check for tears, folds or irregularities of the sample. The 
slides containing samples were incubated overnight in an oven (65°C) to remove excess 
paraffin. 
 
Hematoxylin and Eosin Stain 
 The Hematoxylin and Eosin stain was used to visualize cell nuclei in spheroid 
samples. The reagents used were as follows: Hematoxylin I (Richard-Allan, #7221, 
Thermo Scientific, Waltham, Massachusetts), Clarifier I (Richard-Allan, #7401), Bluing 
Reagent (Richard-Allan, #7301, Thermo Scientific, Waltham, Massachusetts), Eosin-Y 
(Richard-Allan, #7111, Thermo Scientific, Waltham, Massachusetts ). The protocol for 
this stain was prepared by Linda Jenkins, HT (ASCP). For spheroids, our lab has found 
that 8 minutes was suitable for proper staining of nuclei and that 45 seconds was the time 
required for proper staining of cytoplasmic materials. Exceeding these mentioned times 
can lead to over-staining. 
Masson’s Trichrome Stain 
 The Masson’s Trichrome stain was used to visualize ECM in spheroid samples 
and performed according to the manufacturer’s protocol (Masson’s Trichrome Method 
for Connective Tissue, Poly Scientific R&D Corporation). When using the Analine Blue 
reagent, we report that 20 minutes (instead of the recommended 5 minutes) is the most 
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suitable time for ECM visualization in spheroids. Slides containing spheroids were placed 
onto trays and stains were applied using a transfer pipette, rather than dipping the slides 
into reagents. This technique prevents spheroids from being washed off of the slides 
during the staining process. 
 
Tissue Sheet Viability 
 
 After three days of fusion, tissue sheets were fixed overnight using Z-Fix and 
their viability was qualitatively studied using a LIVE/DEAD cell viability assay (Life 
Technologies, CA, USA) with confocal microscopy. The staining was performed 
according to the manufacturer’s protocol and imaged using a Nikon Eclipse Ti 
microscope.  
 
Immunohistochemistry for Functional Protein Markers 
 
Immunofluorescence microscopy was used to qualitatively confirm SMC 
phenotypic expression within tissue tube samples that had fused for 7 days. First, OCT 
embedded histology sections (5 μm thick) were collected and cleared via two washes (5 
min) in PBS and 1 wash in water.  Samples were circled with a diamond tip pen.  
Samples were treated with a 0.1% Triton X-100 to permeabilize samples (10 min).  Slides 
were washed 3x with water (5 min), followed by a 30 minute incubation with 
Background Buster (Innovex Biosciences, CA, USA). Next, samples were washed 2x 
water and 1x PBS.  Once samples were prepped, they were incubated with primary 
antibodies overnight at 4 °C in a humid chamber.  Samples were washed 3x PBS, 
followed by incubation with secondary antibodies for one hour at room temperature. As a 
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control, samples were incubated with just the secondary antibody to ensure controlled 
binding was occurring.  Finally, samples were washed 3x PBS followed by incubation 
with Hoechst 33342 to stain for nuclei (10 min, room temperature).  Samples were 
washed 3x PBS and cover slipped, and fluorescently imaged for Smooth Muscle Myosin 
Heavy Chain (SMHC) and Smooth Muscle 22 (SM22) (FITC, Ex/Em 492/520), Smooth 
Muscle Alpha Actin (SMAA) (Cy3, Ex/Em 552/570), and nuclei (Hoescht 33342, Ex/Em 
343/483) using a Nikon Eclipse Ti microscope. SMHC, SM22 and SMAA are known 
phenotypic markers of smooth muscle cells. Three tissue samples of were analyzed to 
confirm that results were consistent. 
 
Imaging 
 Stained spheroid sections were imaged using a Nikon (Tallahassee, Florida) 
AZ100 multizoom microscope. Images were processed using NIS-Elements software 
package from Nikon. 
 
2.3 RESULTS 
2.3.1 INDIVIDUAL JMCSS 
 The hematoxylin and eosin stains demonstrate the presence of nuclei in cellular 
spheroids at Day 3 and Day 40 time points in spheroids with no iron oxide (Figure 2.2 
A,B) and spheroids with iron oxide MNPs (Figure 2.2 C,D). The cells preferentially 
align themselves over time to reduce configurational energy in both spheroid types, as is 
expected [29, 35]. The Masson’s Trichrome stain demonstrates the presence of ECM in 
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cellular spheroids at Day 3 and Day 40 time points in spheroids with no iron oxide 
(Figure 2.3 A,B) and spheroids with iron oxide MNPs (Figure 2.3 C,D). The ECM 
content increases in both spheroid types over time, as visualized by the increase in the 
amount of blue stain throughout the spheroids.  
 
2.3.2 TISSUES COMPOSED OF JMCSS 
 Histological examination of the tissue sheets and tubes shows that the manual 
processing method yielded intact tissue structures with preserved morphology. Tissue 
sheet sections were stained using an H&E stain and demonstrate the presence of cell 
nuclei throughout the fused tissues after 3 days (Figure 2.4A). The Masson’s Trichrome 
stain demonstrates the presence of collagenous ECM throughout the fused tissue (Figure 
2.4B). A LIVE/DEAD stain of the fused tissue sheet qualitatively confirms the presence 
of viable cells throughout the tissue, as seen by the large population of viable (green) 
cells with only a small portion of dead (red) cells (Figure 2.4C). Tissue tube sections 
were also stained using H&E stain and demonstrate the presence of cell nuclei throughout 
the fused tissue after 7 days (Figure 2.5A). The Masson’s Trichrome stain demonstrates 
that collagenous ECM is present throughout the tissue tube (Figure 2.5B). Tissue tubes 
were fluorescently stained for known phenotypic smooth muscle cell markers: smooth 
muscle myosin heavy chain (SMHC) (Figure 2.5C), smooth muscle 22 (SM22) (Figure 
2.5D) and smooth muscle alpha actin (SMAA) (Figure 2.5E). Results demonstrate 
positive expression of each of these key phenotypic markers in the tissue tubes (red for 
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SMHC and SM22, green for SMAA), as well as the presence of nuclei throughout the 
tissue using a Hoechst stain for nuclei (blue). 
 
 
 
 
 
 
Figure 2.2. Hematoxylin and Eosin Stains of Cellular Spheroids Over Time. Cellular 
spheroids were collected at Day 3 and Day 40 time points. Spheroids were fixed, 
sectioned and then stained with hematoxylin and eosin. (a, b) Hematoxylin and eosin 
stains of Day 3 and Day 40 cellular spheroids. (c, d) Hematoxylin and eosin stains of Day 
3 and Day 40 Janus magnetic cellular spheroids. Here, the iron oxide magnetic 
nanoparticles are black in the images. When compared to Day 3 spheroids, the Day 40 
spheroids have preferentially aligned themselves in both spheroid types. (NIO = no iron 
oxide, JMCS = Janus magnetic cellular spheroid). Magnification = 20x. Scale = 500 μm. 
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Figure 2.3. Masson’s Trichrome Stains of Cellular Spheroids Over Time. Cellular 
spheroids were collected at Day 3 and Day 40 time points. Spheroids were fixed, 
sectioned and then stained using a Masson’s Trichrome staining kit. (a, b) Masson’s 
Trichrome stains of Day 3 and Day 40 cellular spheroids. (c, d) Masson’s Trichrome 
stains of Day 3 and Day 40 Janus magnetic cellular spheroids. Here, the iron oxide 
magnetic nanoparticles are black in the images. The ECM content increases in both 
spheroid types over time, as visualized by the increase in the amount of blue stain 
throughout the spheroids (NIO = no iron oxide, JMCS = Janus magnetic cellular 
spheroid). Magnification = 20x. Scale = 500 μm. 
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Figure 2.4. Histological Examination of Tissue Sheets Composed of JMCSs. Tissue 
sheets composed of magnetically patterned JMCSs were left to fuse for 3 days. After 
three days, tissue sheets were fixed, processed, sectioned and then stained using an H&E 
stain (Figure 2.4A), a Masson’s Trichrome stain (Figure 2.4B) and a LIVE/DEAD 
viability stain (Figure 2.4C) (Scale Bars = 500 μm). The H&E stain demonstrates the 
presence of cell nuclei throughout the fused tissue sheet. Nuclei are visualized as blue or 
dark purple and cytoplasmic tissue elements are visualized as various shades of pink. The 
Masson’s Trichrome stain demonstrates the presence of collagenous ECM throughout the 
fused tissue sheet. Nuclei are visualized as dark red, collagen is visualized as blue, and 
cytoplasmic tissue elements are visualized as various shades of red or pink. The iron 
oxide magnetic nanoparticles are black in the images. The LIVE/DEAD stain 
demonstrates that the tissue contains a large population of viable cells (green), with a 
small population of dead cells (red) after 3 days of fusion. 
 
 
 
Figure 2.5. Histological Examination of Tissue Tubes Composed of JMCSs. Tissue 
tubes composed of fused JMCS tissue sheets were left to fuse for 7 days. After 7 days, 
tissue tubes  were fixed, processed, sectioned and then stained using an H&E stain 
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(Figure 2.5A), Masson’s Trichrome stain (Figure 2.5B), or fluorescent IHC markers for 
smooth muscle cell phenotype analysis (Figures 2.5C, 2.5D and 2.5E) (Scale Bars = 5 
mm for Figures 2.5A and 2.5B; Scale Bars = 500 μm for Figures 2.5C, 2.5D and 2.5E). 
The H&E stain demonstrates the presence of cell nuclei throughout the fused tissue tube, 
as well as the gross structure of the tissue tube. Nuclei are visualized as blue or dark 
purple and cytoplasmic tissue elements are visualized as various shades of pink. The 
Masson’s Trichrome stain demonstrates the presence of collagenous ECM throughout the 
fused tissue tube. The iron oxide magnetic nanoparticles are black in the images. Results 
of staining tissue tube sections for smooth muscle cell phenotypic markers demonstrated 
positive expression of SMHC (red) (Figure 3C), SM22 (red) (Figure 3D) and SMAA 
(green) (Figure 3E). The presence of nuclei throughout the tissue was demonstrated using 
a Hoechst stain for nuclei (blue). 
 
 
2.4 DISCUSSION 
 
 Cellular spheroids are attractive for use as the building blocks for larger and more 
complex tissues because they mimic the 3D native orientation of tissues and produce 
their own ECM over time [11, 69]. The bottom up, scaffold free tissue engineering 
approach with cellular spheroids is promising for the fabrication of larger tissues because 
industrial systems are being developed to robotically scale tissue and organ fabrication 
using automated spheroid bioprinters [69]. Spheroids with tissue specific functions 
(hepatic, cardiac, bone, pancreatic, vascular) have been fabricated, which gives promise 
to the developing technology [36, 70, 140-146]. Cellular spheroids are beginning to be 
used in an industrial setting to fabricate micro-tissues for tissue fabrication and drug 
screening, both of which are critical needs in the clinical setting [147]. High throughput 
drug screening with cellular spheroids would drastically decrease testing time for safety 
and efficacy and limit testing on animals. 
 To compare tissues fabricated in vitro from spheroids to native tissues, it is 
critical to develop an automated method to rapidly process these tissues for histological 
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examination of tissue structure, cellular orientation and ECM organization.  Tissues 
composed of spheroids are subject to poor mechanical properties, due to their fluidic 
nature and lack of maturation [39]. Thus, care must be taken with these delicate samples 
to preserve tissue integrity and tissue morphology during the processing steps.  
 In this work, a manual histological processing technique for spheroids and tissues 
composed of spheroids was presented. This technique uses overnight fixation and also 
overnight infiltration in paraffin. The chosen manual method of processing has been 
compared to automatic processing with a SAKURA Tissue TEK VIP. When using the 
automatic processor, spheroid samples have been lost and tissues composed of spheroids 
have had their morphologies compromised. This is especially critical for tissue tubes 
composed of spheroids, where it is important to maintain the morphology of the lumen 
for further analysis of cells, markers, and ECM distribution. In general, tissue samples 
composed of spheroids are delicate and the manual processing allows for proper care to 
be taken. Manual processing allows for careful solution exchanges and prevents samples 
from being lost because the sample can always been visualized. This research offers a 
reliable method for preparing tissues to study the localization and viability of cells, the 
organization of extracellular matrix and phenotypic expression of tissues composed of 
cellular spheroids. This understanding is critical when developing tissue engineered 
constructs that mimic native tissue. Though the method is sufficient for small scale 
histological analyses, an automated histological processer must be developed in the future 
to meet the need at the industrial scale. Morales and coworkers developed a method to 
rapidly fix, process and embed tissue specimens in 1 hour by using a continuous flow of 
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the working solutions [148]. Another strategy for making the process more high-
throughput could be to embed multiple spheroid samples throughout the same paraffin 
block, which reduces the amount of blocks to be made and sectioned [149].  
 Using the manual technique presented here, tissues of various shape, size and 
composition were able to be processed and prepared for histological examination. 
Sectioned specimens were stained using H&E, Masson’s Trichrome, LIVE/DEAD and 
various IHC reagents. The H&E stain allowed for visualization of cell nuclei, the 
Masson’s Trichrome stain highlighted collagen throughout the tissue, the LIVE/DEAD 
stain demonstrated high cell viability in tissue sheets and IHC staining demonstrated 
phenotypic expression expected of smooth muscle cells. These results qualify the 
presented manual method of tissue processing for preparing tissues for standard stains, 
like H&E, as well as specialized stains, like fluorescent IHC staining. The presented 
method allowed for visualization of cells, characterization of collagen, localization of 
iron oxide MNPs and analysis of phenotypic expression throughout tissues composed of 
cellular spheroids. Having a full understanding of these tissue molecules and components 
is critical for developing a tissue engineered construct that mimics native tissue. 
Currently, conventional histological processors are not recommended to process spheroid 
anatomic qualities and preserve morphological properties because of the risk for sample 
dissipation and degradation. In the future, automated processors with fine meshed biopsy 
bags, custom processing cassettes, EM tissue processing techniques and cryosection 
techniques offer shorter potential turn-around times and will need to be developed, tested 
and compared to the presented paraffin technique in the future.  
69 
 
2.5 CONCLUSIONS 
 Given their widespread use in developmental biology, drug discovery and testing, 
and tissue engineering, it is critical to further develop a method for preparing spheroids 
and tissues composed of spheroids for histological examination in a rapid manner to 
visualize and understand tissue structure, morphology and composition. Due to their 
small size and delicate nature, spheroids cannot be fixed and dehydrated using 
conventional histological automated tissue processors, and must be processed manually. 
To accommodate numerous samples for high throughput histological analysis of 
spheroids, an automated technique will be required to address the turn-around time and 
eliminating possible user error. In the future, the development and optimization of stains 
for spheroids and tissues composed of spheroids, like stains for localizing metallic 
nanoparticles or markers for immunohistochemistry, will be required for developing a 
better understanding of the tissues and their interactions with nanomaterials. This study 
confirms that the method described here is suitable for processing and preparing 
spheroids and tissues composed of spheroids for histological examination. 
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CHAPTER 3 
FUSION OF JANUS MAGNETIC CELLULAR SPHEROIDS 
3.1 INTRODUCTION 
A major challenge in tissue engineering is the in vitro fabrication of functional 
tissue constructs with cell numbers, extracellular matrix (ECM) contents and mechanical 
properties that mimic the native vasculature [36]. Scaffold-free cellular aggregates, or 
spheroids, produce their own ECM, allow for precise control over cell number and can 
fuse into complex tissue structures [11, 29, 34, 48]. Stimulation of ECM production and 
tissue fusion is critical for the fabrication of complex tissue structures using spheroids 
[34]. The formation of a network of ECM between and throughout adjacent spheroids is 
critical for structural integrity and provides cues for the fusion process. Tissue fusion is a 
self-assembly process in which two or more distinct cell populations, or tissues, make 
contact and coalesce to form a single cohesive structure [11, 29, 34]. Factors mediating 
tissue fusion include cell migration, cell-cell interactions, and cell-matrix interactions 
[29, 30, 34] to minimize the overall system configurational energy, which results in 
smaller tissue aggregates [12, 29]. Tissue contraction, which includes intracellular 
cytoskeletal reorganization from cadherin-mediated adhesions, is thought to be 
responsible for the conformational changes that cause fused tissues of complex 
geometries to resolve into spheroids over time [50, 150].  
Conventional tissue assembly and fabrication methods include cell printing, cell 
sheet techniques, and patterned molds [11, 26, 29, 62]. These methods spatially orient the 
cells and tissues into a desired position to create passive contacts, but do not promote 
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active contact between cells and tissues to accelerate the tissue fusion process. Therefore, 
the preparation of homogenous or cohesive engineered tissues remains a challenge when 
using scaffold-free cellular aggregates. By incorporating magnetic nanoparticles (MNPs) 
into cellular spheroids, these self-assembled tissues can be aligned and patterned using 
magnetic force assembly [88, 90, 92, 93, 97, 151, 152]. Our lab developed the Janus 
structure of magnetic cellular spheroids (JMCSs), which provides spatial control of iron 
oxide MNPs to form two distinct domains: cells and extracellular MNPs [78]. Mattix and 
coworkers reported that iron oxide MNPs do not adversely affect the viability of JMCSs 
and that magnetic forces accelerated the fusion of JMCSs [78]. Unlike conventional 
tissue patterning methods, magnetic fields are physical forces used to promote active cell-
cell contacts and interactions that arise from the adhesive and cohesive interactions 
between cells under the influence of magnetic attraction [78].  
 Here, we report our results on manipulating spheroid composition and the effects 
on JMCS fusion mediated by magnetic forces. The objective of this work was to 
determine the mechanisms associated with the fusion of JMCSs. The hypothesis driving 
this work is that spheroid composition, including cell content and ECM content, regulates 
the fusion kinetics of JMCSs. Our results demonstrate the critical role of cell-cell and 
cell-ECM interactions for mediating cellular spheroid fusion and show the potential use 
of magnetic nanoparticles for stimulating ECM production in spheroids. 
3.2 MATERIALS & METHODS 
 An overview of experimental procedures, parameters, and objectives can be found 
in Table 3.1. 
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Table 3.1. Experimental Plan for the Analysis of Collagen Production in Spheroids 
and Factors Affecting the Fusion of JMCSs. Experiments were performed to analyze 
the ability of cellular spheroids with and without MNPs to produce collagen over time.  
Furthermore, studies were performed to determine what factors mediate JMCS fusion, 
including cell number, collagen content and time. Cellular intermixing, which is a 
hallmark of tissue fusion, was also analyzed in fusing spheroids. Finally, cell-cell and 
cell-ECM interactions were studied to see the relative impact of each of fusing spheroids. 
Multiple parameters were varied within each experiment as noted.   
 
 
 
Cell Culture 
 
 Primary rat aortic smooth muscle cells were isolated from the aorta via careful 
removal of the adventitia and endothelial cell lining, followed by a one hour incubation 
with trypsin (0.25%) and collagenase (5 units/mL). Only passage numbers under ten were 
used. All cells were cultured in monolayer cultures at 37 °C and 5% of CO2 until 
spheroid assembly. SMCs were cultured using Dulbeco’s Modified Eagle Medium:F-12 
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(ATCC, 1:1, DMEM:F-12) supplemented with 10% fetal bovine serum (Atlanta 
Biologics) and 1% penicillin-streptomycin-amphotericin (MediaTech, Inc.). 
 
Spheroid Assembly 
  
 Spheroids (Janus Magnetic Cellular Spheroids and No Iron Oxide Spheroids) 
were prepared using a method developed in our lab and previously described [76-78]. 
Equal volumes of solutions containing suspended iron oxide MNPs (Fe3O4, 20-30 nm, 
SkySpring Nanomaterials, Inc.), collagen (Bovine, Type I, Life Technologies), and cells 
in cell culture media were combined and dispensed as hanging drops (15 μL) to form 
spheroids. Collagen, Type I was prepared according to the manufacturer 
recommendations and kept on ice prior to use for all samples. Collagen was only added at 
the time of spheroid fabrication and not continuously added to the media. Formulations 
calling for no collagen were replaced with an equal volume of media. Unless otherwise 
noted, all spheroids were incorporated into studies after three days of incubation. 
 
Controlling Collagen Content During Spheroid Fabrication 
 Collagen was only added to spheroids during the fabrication process and not 
continuously supplemented in the media. To demonstrate that collagen content within 
spheroids can be controlled during spheroid formation, histological examination with a 
Masson’s Trichrome stain was used after 3 days of spheroid formation with varying 
collagen contents (0.017 mg/mL, 0.1 mg/mL and 0.25 mg/mL).  
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Viability 
 
 PrestoBlue cell viability assays were performed according to manufacturer’s 
protocol (Life Technologies) in order to quantify cell viability, with at least 3 repeats per 
sample. Spheroids were first dissociated via incubation with collagenase (5 units/mL) 
(Collagenase Type IV), followed by incubation with trypsin (0.25%), and adherence 
overnight on a well plate. 
 
Spheroid Sizing 
 Spheroids with 5,000 cells per spheroid and 20,000 cells per spheroid were 
fabricated and left to form for 3 days. After 3 days, spheroids were imaged using a Nikon 
AZ100 microscope and their diameters measured using NIS Elements (Nikon) software 
package. 
 
Ring Fusion 
 
 Spheroid fusion was analyzed by tracking the fusion of spheroids into a ring. Ring 
magnets were commercially purchased (2 mm OD, 1 mm ID, 1 mm thick, Super Magnet 
Man) and attached to the bottom of a glass chamber slide. 25 individual spheroids of the 
same formulation were carefully patterned around the ring pattern in a monolayer 
formation. The low concentration (0.005 mg/mL) represents a minimal amount of 
collagen added to spheroids. The high collagen concentration (0.3 mg/mL) represents the 
most collagen that could be incorporated into the spheroids and still allow for placement 
into a ring structure with a lumen. Magnets were removed after 48 hours and samples 
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imaged using a Nikon AZ100 multizoom microscope. Four measurements for each ring 
diameter were recorded (vertical, horizontal and two diagonals) and averaged at each 
time point. Samples were normalized with themselves, as each sample was analyzed as 
the percent initial diameter. At least three repeats were performed for each sample. 
 
Collagen Quantification 
 
 The collagen content in spheroids was determined using a hydroxyproline assay, 
as previously described [153]. First, spheroids were hydrolyzed in 4N sodium hydroxide 
at 120˚C for 2 hours. Samples were neutralized with 1.4N citric acid and pH balanced to 
a range of 7.2 to 7.6. A hydroxyproline standard curve was prepared for calibration of 
unknown samples. An aliquot of 200 µL was taken from each sample to be incubated 
with a Chloramine T solution for 15 minutes and then a p-Dimethylaminobenzaldehyde 
solution for 15 minutes at 65˚C. Next, experimental samples were prepared as triplicates 
for optical number readings at 550 nm. Unknown samples were calculated based on the 
hydroxyproline standard curve. Long term spheroid collagen content studies were 
normalized to each respective group’s collagen content at Day 3. 
 
Capillary Tube Fusion with Varying Collagen Content and Cell Numbers 
 
 Capillary tubes (500 µm diameter, CTechGlass, CT95-02) were used to study the 
influence of collagen content and cell number on cellular spheroid fusion. JMCSs 
composed of primary rat aortic smooth muscle cells were assembled and four of them 
were placed into capillary tubes full of cell culture media. The first treatment was varying 
collagen concentrations incorporated into spheroids, which were 0.017 mg/mL and 0.24 
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mg/mL bovine collagen I (Life Technologies). The low concentration represents the 
amount of collagen used for making rounded spheroids with some structural support. The 
high collagen value represents the most collagen that could be incorporated into the 
spheroids and still allow for placement in the capillary tubes without clogging. For the 
varying collagen study, 20,000 cells per spheroid were used. The second treatment was 
varying the cell numbers that were incorporated into spheroids, which were 5,000 cells 
per spheroid and 20,000 cells per spheroid. For the varying cell number study, 0.017 
mg/mL collagen concentration was used. Spheroid filled capillary tubes were placed 
upright into 0.65 mL polypropylene conical tubes with cell culture media to allow 
spheroids to settle to the bottom. Samples were exposed to magnetic forces by placement 
on top of square magnets (K&J Magnetics, Inc., B881). Immediately after placement into 
capillary tubes, the spheroids were imaged using an AMG EVOS fl Digital Inverted 
Microscope to get initial diameter measurements of the spheroids using ImageJ. To 
ensure that no gaps existed between the spheroids and complete contact existed, the 
samples were exposed to magnetic forces prior to initial measurements. Spheroids were 
left in capillary tubes for 24 and 48 hours prior to further imaging analysis. The 24 and 48 
hour spheroid measurements were normalized to the initial measurements. At least three 
repeats were used for each condition to confirm repeatability. 
 
Cellular Intermixing 
 
 Rat aortic smooth muscle cell solutions were fluorescently labeled using a 
Vybrant® CFDA SE Cell Tracer Kit (green) or PKH26 Red Fluorescent Cell Linker Kit 
(red). Stains were performed according to manufacturer protocols (Life Technologies). 
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The stained cell solutions were then used to fabricate JMCSs with varying collagen 
concentrations (0.017 mg/mL and 0.24 mg/mL). The low concentration represents the 
amount of collagen used for making rounded spheroids with some structural support. The 
high collagen value represents the most collagen that could be incorporated into the 
spheroids and still allow for placement in the capillary tubes without clogging. 
Alternating in color, four spheroids were gently placed into capillary tubes (500 µm 
diameter, CTechGlass, CT95-02). After 48 hours, fluorescent images were captured using 
a Nikon Ti Eclipse microscope. The ratio view tool on NIS-Elements Software from 
Nikon Instruments was used to visualize and compare cellular intermixing of the 
fluorescently labeled spheroids. The ratio view function allows measurement of the ratio 
of two wavelengths across multiple regions of interest and shows the ratio value by pixel. 
 
Fusion Blocking 
 
 To understand the influences of various cell-cell and cell-matrix proteins on 
spheroid fusion their functional capacity was inhibited. Four spheroids were gently 
placed into capillary tubes (500 µm diameter, CTechGlass, CT95-02). Spheroid filled 
capillary tubes were placed upright into a 0.65 mL polypropylene conical tube with cell 
culture media to allow spheroids to settle to the bottom. Samples were exposed to 
magnetic forces via placement of a square magnet below sample containers (K&J 
Magnetics, Inc., B881). The media used in the capillary tubes and conical tube was 
supplemented with the following in order to inhibit the function of cell-cell and cell-
matrix interactions: monoclonal anti-N-cadherin antibody (clone GC-4, Sigma) (40 
μg/mL), for inhibiting cell-cell interactions regulated by cadherins; and Anti-Mouse/Rat 
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CD29 Functional Grade Purified (eBioscience) (5 μg/mL), for inhibiting the cell-matrix 
interactions of integrin beta 1. After supplementation, spheroids were immediately 
imaged using an AMG EVOS fl Digital Inverted Microscope and their diameters 
measured using ImageJ. Fused tissue constructs were then imaged again at 48 hours and 
their lengths measured. Samples were normalized with themselves over time and at least 
five repeats were used for each treatment. The fusion of the treated samples was 
compared to control samples without fusion blockers. 
 
Histology 
 
 All samples were processed and sectioned via paraffin sectioning techniques 
developed in our lab [137]. Spheroids were fixed, processed (5 µm sections), and stained 
using either hemotoxylin and eosin (H&E) or Masson’s Trichrome stain. 
 
Statistical Analysis 
 
 Statistical analyses were performed using an Analysis of Variance (ANOVA) test 
to determine if differences were present amongst treatment groups. If differences were 
determined from the ANOVA, a post hoc two tailed t-test was used to determine if 
significant differences existed between treatment groups. Error bars on graphs represent 
the standard deviation from the mean. 
3.3 RESULTS 
3.3.1 COLLAGEN PRODUCTION IN SPHEROIDS OVER TIME 
 The development of a viable tissue engineered construct with mechanical 
properties similar to native tissues heavily relies on enhancing collagen production. An 
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appealing aspect of cellular spheroids for tissue engineering applications is their ability to 
dynamically produce their own ECM to meet required mechanical or functional needs of 
the local environment [48]. Copper and iron ions have been shown to enhance collagen 
crosslinking in tissues, modulate collagen gene expression and regulate intracellular 
elastin production, which are critical for the organization and maturation of engineered 
tissues [154-156]. Patients with beta-thalassaemia and other inherited hemolytic disorders 
characterized with fluctuations in iron concentration demonstrate defective elastic fibers 
[156]. Also, it has been shown that iron is associated with gene expression of encoding 
ECM components [155]. Here, we tested the hypothesis that iron, a physiologically 
essential nutritional element, could be associated with stimulating production of ECM 
when iron oxide MNPs are integrated into cellular spheroids.  
 JMCSs and spheroids without MNPs were fabricated and incubated over 40 days 
in cell culture media or cell culture media supplemented with ascorbic acid (50 µg/mL), 
which is known to stimulate collagen production [26]. Initial collagen concentrations 
were held constant at 0.017 mg/mL for spheroids with and without MNPs. Collagen 
contents of different spheroid types were normalized to each group’s respective collagen 
content at Day 3 to eliminate the contribution of the initial collagen added to spheroid 
during the preparation. Results of hydroxyproline assays qualitatively demonstrate 
increased collagen production in all spheroid types over time (p < 0.05, indicated by ‘+’) 
(Figure 3.1). Results demonstrated that the addition of iron oxide MNPs in JMCSs 
caused a significant increase in collagen production, when compared to their NIO 
counterparts at Day 40 (p<0.05, as indicated by ‘_’).  Further, the addition of ascorbic 
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acid significantly increased ECM production of both spheroid types (p<0.05, as indicated 
by ‘#’ for NIO and AANIO and ‘*’ for JMCS and AAJMCS groups). It should be noted 
that the combination of Janus spheroids with ascorbic acid had a synergistic effect, as the 
collagen content in these spheroids was significantly greater than in spheroids with 
ascorbic acid supplementation and no MNPs (p<0.05, as indicated by ‘=’). Compared to 
Day 3, at Day 40 NIO spheroids had 4.68 times more collagen content, ascorbic acid 
treated NIO spheroids had 6.76 times more collagen content, JMCS spheroids had 6.32 
times more collagen content and ascorbic acid treated JMCS spheroids had 8.21 times 
more collagen content. Next, spheroids were histologically sectioned and stained with 
hematoxylin and eosin and Masson’s Trichrome stains to visualize nuclei and collagen, 
respectively, at Day 10, 20, 30 and 40 time points (Figure 3.1). It is expected that the 
spheroids containing iron oxide magnetic nanoparticles will be larger in diameter, when 
compared to spheroids without magnetic particles. To confirm that these two groups 
contained similar collagen contents at the beginning of the study, a hydroxyproline assay 
was used to quantify collagen at Day 3 for each group. Results showed that though the 
spheroids differed in size, the collagen content is the same after incorporation of the 
collagen and MNPs during spheroid formation (Figure 3.2). Histological examination 
suggests that JMSCs and MNP-free spheroids secrete their own collagen, as visually 
confirmed by an increase in collagen within cellular spheroids over time. As expected, 
supplementation with ascorbic acid increased collagen production over time in tissue 
sections. When sectioning spheroids, it is difficult to obtain sections at the same depth in 
different spheroid populations, which led to the variability in size for tissue sections. 
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Overall, these results demonstrate that iron oxide MNPs stimulate and enhance collagen 
synthesis when compared to MNP-free controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Effect of Iron Oxide MNPs on Collagen Synthesis within JMCSs. Results 
of hydroxyproline assays qualitatively demonstrate increased collagen production in NIO, 
AANIO, JMCS and AAJMCS spheroids over 40 days (p<0.05, as indicated by +). 
Results demonstrated that the addition of iron oxide MNPs in JMCSs caused a significant 
increase in collagen production, when compared to their NIO counterparts (p<0.05, as 
indicated by ‘_’).  Further, the addition of ascorbic acid significantly increased ECM 
production of both spheroid types (p<0.05, as indicated by ‘#’ for NIO and AANIO and 
‘*’ for JMCS and AAJMCS groups). It should be noted that the combination of Janus 
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spheroids with ascorbic acid had a synergistic effect, as the collagen content in these 
spheroids was significantly greater than in spheroids with ascorbic acid supplementation 
and no MNPs (p<0.05, as indicated by ‘=’). Results of the Masson’s Trichrome stain 
suggest that all spheroid samples secrete their own collagen over time (increase in blue), 
which indicates that MNPs have no adverse effects on collagen synthesis within cellular 
spheroids. NIO= No Iron Oxide, AANIO=Ascorbic Acid No Iron Oxide, JIO=Janus Iron 
Oxide, AAJIO=Ascorbic Acid Janus Iron Oxide. 
 
  
Figure 3.2. Collagen Content in Day 3 Spheroids With and Without MNPs.  After 
three days, no iron oxide spheroids and JMCSs were collected and their collagen contents 
analyzed using a hydroxyproline assay. Results demonstrate that there is no difference 
between the collagen contents in spheroids with and without magnetic nanoparticles 
(p>0.05) after three days. 
 
 The cell number of a tissue engineered construct is critical for functionality [11, 
29, 157]. Here, JMCSs with 5,000 cells per spheroid and 20,000 cells per spheroid were 
fabricated and incubated in cell culture media over 40 days. Initial collagen 
concentrations were held constant at 0.017 mg/mL for spheroids with and without MNPs. 
Collagen contents of different spheroid types were normalized to each group’s respective 
collagen content at Day 3. Qualitative results showed that both spheroid types produced 
collagen over time (p < 0.05, as indicated by ‘+’) (Figure 3.3). These results indicate that 
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lower cell number spheroids produce similar amounts of collagen, relative to high cell 
number samples, as there were not significant differences between samples at Day 20, 
Day 30 and Day 40 time points (p > 0.05). The results show that lower cell number 
spheroids produce more collagen, relative high cell number samples, as there was 
significant differences between samples at Day 10 (p<0.05, as indicated by ‘*’). This 
suggests that the differences in cell number may not be significant after the spheroids are 
incubated for 10 days or more, which would lead to similar collagen production between 
the two groups. Spheroids were histologically sectioned and stained with hematoxylin 
and eosin and Masson’s Trichrome stains to visualize nuclei and collagen, respectively, at 
Day 10, 20, 30 and 40 time points (Figure 3.3). It is expected that the size of the spheroid 
will be different among 5,000 and 20,000 cell per spheroid samples. Spheroids with each 
cell density were collected after three days of formation, imaged and their diameters 
measured. Results show that 20,000 cell per spheroid samples were significantly larger 
than the 5,000 cell per spheroid counterparts (Figure 3.4), which was anticipated due to 
the presence of more cells. A histological examination demonstrated that both cell 
densities had cell nuclei through the spheroid and that each saw an increase in collagen 
production over time, as seen by the increase in blue staining throughout the samples 
from the Masson’s Trichrome stain. Again, the variability in the size of the spheroid 
sections can be attributed to difficulty in sectioning spheroids at the same depth amongst 
different spheroid groups. 
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Figure 3.3. Effect of Cell Number on Collagen Synthesis within JMCSs. Results of 
hydroxyproline assays qualitatively demonstrated increased collagen production in 
spheroids with both, 5,000 and 20,000 cell per spheroid samples over 40 days (p<0.05, as 
indicated by ‘+’). The results indicate that lower cell number spheroids produce similar 
amounts of collagen, relative to high cell number samples, as there were not significant 
differences between samples at Day 20, Day 30 and Day 40 time points (p > 0.05). The 
results show that lower cell number spheroids produce more collagen, relative high cell 
number samples, as there was significant differences between samples at Day 10 (p<0.05, 
as indicated by ‘*’). This suggests that the differences in cell number may not be 
significant after the spheroids are incubated for 10 days or more, which would lead to 
similar collagen production between the two groups. Results of the Masson’s Trichrome 
stains suggest that all spheroid samples produce their own collagen over time (increase in 
blue stain), which indicates that cell number has no adverse effects on collagen synthesis 
within cellular spheroids.  
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Figure 3.4. Spheroid Diameter with Varying Cell Numbers at Day 3. After three 
days, spheroids composed of 5,000 and 20,000 cells per spheroid were imaged and their 
diameters measured. Results demonstrate that the 20,000 cells per spheroid samples have 
diameters that are significantly larger than the 5,000 cells per spheroid samples after three 
days of formation (p<0.05, as indicated by ‘*’). These results were anticipated due to the 
presence of more cells in the 20,000 cells per spheroid samples.  
 
3.3.2 FACTORS AFFECTING SPHEROID FUSION 
 
To drive the fusion process for the self-assembly of complex tissues, tissue 
spheroid building blocks must be in direct contact [11]. Morgan’s lab reported modeling 
fusion kinetics of tissue toroids over time, which were fabricated from cell solutions [50, 
52]. Here, the roles of cell number and ECM content were evaluated for their potential to 
influence the fusion of cellular spheroids into a tissue ring. Twenty five JMCSs were 
patterned on ring magnets and left to fuse for 48 hours prior to removal of the magnetic 
forces. After removal of the magnetic template, two phenomena occur: fusion and 
contraction. The individual spheroids in the tissue rings will continue to fuse together, 
while the ring tissue as a whole will contract, or resolve to a rounded spheroid, due to 
forces generated through cell-cell adhesions and actin networks [50, 150, 158]. Images of 
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assembled tissue rings were taken daily and the contraction was quantitatively tracked. 
Complete fusion and contraction was defined as a lack of a lumen within the tissue ring.  
First, the influence of cell number was analyzed with samples both with and 
without ECM. In the presence of ECM (0.017 mg/mL collagen added during fabricaiton), 
results indicated that lower cell numbers, 5,000 cells per spheroid tested here, showed the 
fastest and most complete fusion and contraction over 156 hours when compared to 
higher cell numbers, 20,000 cells per spheroid tested here (84 hr, 108 hr, 132 hr and 156 
hr; p < 0.05, as indicated by ‘*’) (Figure 3.5a). Visual analysis confirmed that low cell 
number rings corresponded to the most complete and accelerated fusion and contraction 
compared to their higher cell number counterparts (Figure 3.5b). 
Next, the effect of ECM content on ring fusion and contraction was studied by 
varying the collagen content added to cellular spheroids during fabrication, while holding 
the cell number constant (20,000 cells per spheroid). To demonstrate that collagen 
content within spheroids can be controlled during spheroid formation, histological 
examination with a Masson’s Trichrome stain was used after 3 days of spheroid 
formation with varying collagen contents added. Results of the stain showed an increase 
in royal blue color throughout the spheroid as the amount of collagen added during 
spheroid formation was increased from 0.017 mg/mL to 0.1 mg/mL to 0.25 mg/mL 
(Figure 3.6a). Presto blue viability assays confirmed that the addition of collagen content 
had no adverse effect on spheroid viability at 1 week in rat aortic smooth muscle cells 
and fibroblasts, when compared to spheroids without collagen added during spheroids 
formation (Figure 3.6b). Results of ring studies showed that lower collagen contents 
a 
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(0.005 mg/mL) demonstrated the fastest and most complete fusion and contraction when 
compared to higher collagen spheroids over time (0.3 mg/mL) (84 hr, 108 hr and 132 hr; 
p < 0.05, as indicated by ‘*’) (Figure 3.7a). Visual analysis highlighted the differences in 
fusion and contraction characteristics based on collagen content (Figure 3.7b).  
Figure 3.5 Effects of ECM on Ring Fusion and Compaction. The effects of varying 
collagen contents for tissue fusion and compaction was quantified over time for rings 
composed of JMCSs with two collagen contents, 0.005 mg/mL and 0.3 mg/mL. (a) At the 
84 hr, 108 hr, and 132 hr timepoints the percent initial ring diameters of the 0.005 mg/mL 
collagen spheroids were significantly smaller when compared to the 0.3 mg/mL collagen 
spheroid counterparts (p<0.05, as indicated by ‘*’).  Four measurements for each ring 
diameter were recorded (vertical, horizontal and two diagonals) and averaged at each time 
point. (b) Visual analysis of ring fusion confirms that collagen content plays a significant 
role in tissue fusion and compaction, with decreases in fusion and compaction becoming 
evident with increasing collagen concentrations.  
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Figure 3.6. Controlling Collagen Content During Spheroid Formation. (a) In order to 
demonstrate that collagen content could be controlled during spheroid formation, 
spheroids were fabricated with a range of collagen concentrations and then histologically 
examined using a Masson’s Trichrome stain after three days of formation. Spheroid 
sections with 0.017 mg/mL, 0.1 mg/mL and 0.25 mg/mL collagen concentrations were 
stained and results show that as the collagen concentration within the spheroid was 
increased during spheroid fabrication, an increase in blue color was seen in spheroid 
sections. This demonstrates that collagen content can be controlled during the formation 
of spheroids. (b) To ensure that a range of collagen contents can be safely incorporated 
into spheroids without adverse effects on cell viability, Presto Blue cell viability assays 
were performed. Spheroids were formed with collagen concentrations that ranged from 
0.01 mg/mL to 1.3 mg/mL. When compared to spheroids without any added collagen, 
results showed that the addition of the collagen during spheroid formation had no adverse 
effects on cell viability through one week. 
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Figure 3.7. Effects of ECM on Ring Fusion and Compaction. The effects of varying 
collagen contents for tissue fusion and compaction was quantified over time for rings 
composed of JMCSs with two collagen contents, 0.005 mg/mL and 0.3 mg/mL. (a) At the 
84 hr, 108 hr, and 132 hr timepoints the percent initial ring diameters of the 0.005 mg/mL 
collagen spheroids were significantly smaller when compared to the 0.3 mg/mL collagen 
spheroid counterparts (p<0.05, as indicated by ‘*’).  Four measurements for each ring 
diameter were recorded (vertical, horizontal and two diagonals) and averaged at each 
time point. (b) Visual analysis of ring fusion confirms that collagen content plays a 
significant role in tissue fusion and compaction, with decreases in fusion and compaction 
becoming evident with increasing collagen concentrations.  
 
 
a 
b 
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To study the influence of collagen on spheroid fusion, 0.017 mg/mL and 0.24 
mg/mL collagen concentrations were used with 20,000 cells per spheroid and 0.3 mg/mL 
iron oxide. To study the influence of cell number on spheroid fusion, 5,000 and 20,000 
cells per spheroid were used with 0.017 mg/mL collagen and 0.3 mg/mL iron oxide. 
Spheroid filled capillary tubes were exposed to magnetic forces via placement of a square 
magnet below sample containers. Results demonstrate that low collagen JMCSs (0.017 
mg/mL) fused into a more cohesive tissue at 24 and 48 hour time points, as the tissue 
construct sizes were 71% and 65% of initial tissue sizes, respectively (Figure 3.8a). High 
collagen spheroids (0.3 mg/mL) experienced minimal fusion, as the tissue construct sizes 
were 93% and 97% of initial tissue sizes are 24 and 48 hour time points, respectively. 
Upon examining the images for low and high collagen groups, the low collagen group 
tissue construct size was statistically significantly lower at both time points when 
compared to the high collagen group (p < 0.05, as indicated by ‘*’). 
 Results demonstrate that low cell number spheroids had fused into constructs that 
were 81% and 68% of initial sizes at 24 and 48 hour time points, respectively (Figure 
3.8b). High cell number spheroids had fused into constructs that were 66% and 59% of 
initial sizes at 24 and 48 hour time points, respectively, which was statistically 
significantly lower than the 5,000 cells per spheroid group at the 24 hour time point (p < 
0.05, as indicated by ‘*’). These results suggest that low collagen content allows for more 
cell to cell interactions and cell contraction, and ultimately faster and more complete 
fusion. With an increase in collagen content, cells become enmeshed in the dense 
collagen network and their mobility is limited. This prevents the formation of cell-cell  
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Figure 3.8. Tissue Fusion in JMCSs with Varying Collagen Content and Varying Cell 
Number Mediated by Magnetic Forces. JMCSs were assembled and placed into capillary tubes 
full of cell culture media. Samples were exposed to magnetic forces via placement of a square 
magnet below sample containers. (a) Results demonstrate that low collagen JMCSs (0.017 mg/mL) 
fused into a more cohesive tissue at 24 and 48 hour time points, as the tissue construct sizes were 
71% and 65% of initial tissue sizes, respectively. High collagen spheroids (0.3 mg/mL) experienced 
minimal fusion, as the tissue construct sizes were 93% and 97% of initial tissue sizes are 24 and 48 
hour time points, respectively. At both timepoints, the tissue construct sizes of the low collagen 
JMCSs were significantly smaller than the high collagen JMCSs (p<0.05, as indicated by ‘*’). 
Visual analysis shows that low collagen spheroids fused into a more homogenous structure after 48 
hours, while the high collagen spheroids fused minimally and the individual spheroids can still be 
seen. (b) Results demonstrate that low cell number spheroids (5,000 cells per spheroid) had fused 
into constructs that were 81% and 68% of initial sizes at 24 and 48 hour time points, respectively. 
High cell number spheroids (20,000 cells per spheroid) had fused into constructs that were 66% and 
59% of initial sizes at 24 and 48 hour time points, respectively, which was statistically significantly 
lower than the 5,000 cells per spheroid group at the 24 hour time point (p < 0.05, as indicated by 
‘*’). Visual analysis shows that both cell types fuse to similar sized constructs after 48 hours. 
a 
b 
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adhesions, which are critical to the fusion process. As the cell number increases and 
collagen content remains constant, there are more opportunities for cell to cell 
interactions and contacts, which is conducive to promoting faster and more complete 
fusion in a smaller amount of time. Spheroids with lower cell numbers provide an 
environment that allows for cells to be mobile and make new cell-cell adhesions, but 
there are not as many of these contacts due to the lower cell number and this could delay 
the fusion of tissues. 
 
3.3.3 CELLULAR INTERMIXING 
 
 A hallmark of tissue fusion is cellular intermixing to create a homogenous tissue 
[150]. Here, we measured the influence of collagen content and cell number on cellular 
intermixing during spheroid fusion in capillary tubes. Spheroids with varying collagen 
content and cell number were fluorescently labeled and allowed to fuse for 48 hours in 
capillary tubes with magnetic forces prior to imaging. Results demonstrated that high 
collagen (0.24 mg/mL) spheroids experienced minimal cellular intermixing (8.6%), as 
demonstrated by the lack of intermixing of fluorescent signal using the ratio view tool in 
NIS-Elements software (Figure 3.9). Low collagen (0.017 mg/mL) spheroids exhibited 
significantly more cellular intermixing (22.1%) between adjacent spheroids, as 
demonstrated by the mixing of fluorescent signal (p<0.05, as indicated by ‘*’). These 
results indicate that collagen content influences cellular intermixing and cell migration, 
which is critical for the fusion process. While collagen content may provide the structural 
support required for developing tissues, these results indicate that collagen can slow 
cellular intermixing and migration, both of which are critical to tissue fusion. 
a 
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 Results from studying the influence of varying cell number on spheroid cellular 
intermixing demonstrated that low cell number  spheroids experienced minimal cellular 
intermixing (10.1%), as demonstrated by the lack of intermixing of fluorescent signal 
using the ratio view tool in NIS-Elements software (Figure 3.10). High cell number 
spheroids had significantly more cellular intermixing (22.1%) between adjacent 
spheroids, as demonstrated by the mixing of fluorescent signal (p<0.05, as indicated by 
‘*”). These results indicate that cell number influences cellular intermixing and cell 
migration, which are both important during the fusion process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Cellular Intermixing in JMCSs with Varying Collagen Content. 
Spheroids with varying collagen content and cell number were fluorescently labeled and 
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allowed to fuse for 48 hours in capillary tubes with magnetic forces prior to imaging. (a) 
Results demonstrated that high collagen (0.24 mg/mL) spheroids experienced minimal 
cellular intermixing (8.6%), as demonstrated by the lack of intermixing of fluorescent 
signal using the ratio view tool in NIS-Elements software. Low collagen (0.017 mg/mL) 
spheroids had more significantly more cellular intermixing (22.1%) between adjacent 
spheroids, as demonstrated by the mixing of fluorescent signal (p<0.05, as indicated by 
‘*’). 
Figure 3.10. Cellular Intermixing in JMCSs with Varying Cell Number. Results from 
studying the influence of varying cell number on spheroid cellular intermixing 
demonstrated that low cell number (5,000 cells per spheroid) spheroids experienced 
minimal cellular intermixing (10.1%), as demonstrated by the lack of intermixing of 
fluorescent signal using the ratio view tool in NIS-Elements software. High cell number 
spheroids (20,000 cells per spheroid) had significantly more cellular intermixing (22.1%) 
between adjacent spheroids, as demonstrated by the mixing of fluorescent signal (p<0.05, 
98 
 
as indicated by ‘*’). These results indicate that cell number influences cellular 
intermixing and cell migration, which are both important during the fusion process. 
 
3.3.4 CELL-CELL AND CELL-ECM INTERACTIONS 
 The biological relevance of self-assembly of spheroids [159] and even the forces 
driving the self-assembly of tissue [51] have been reported. However, there is a gap in the 
literature regarding the influence of cell-cell and cell-matrix proteins on tissue fusion. 
Work by Lin and coworkers describes studying the effect of cadherins and integrins 
during spheroid formation using hepatoma spheroids, yet not much is known about the 
role of integrins and cadherins during spheroid fusion [160]. To study cell-cell 
interactions in fusing spheroids, we tested the inhibition of cadherins, which are a family 
of glycoproteins involved in calcium dependent cell adhesion. Studies have shown that 
inhibition with anti-cadherin antibodies induced dissociation of two dimensional cell 
layers [161]. Integrins are major adhesion receptors and span across the cell membrane. 
They are responsible for regulating cell to ECM binding and making transmembrane 
connections to the cytoskeleton to activate intracellular signaling pathways. The 
concentrations of cadherin and integrin blockers were 40 μg/mL and 5 μg/mL, 
respectively, which are comparable to work using blockers in studies with forming 
spheroids by Lin and toroids by Morgan [51, 160].  Results demonstrated that spheroids 
with functional inhibition of cadherins exhibited tissue construct sizes that were 81% of 
the initial sizes after 48 hours (Figure 3.11). For cell-ECM interactions, results showed 
that spheroids with functional inhibition of integrins exhibited tissue construct sizes that 
were 85% of the initial sizes after 48 hours (Figure 3.11). Control spheroids without 
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fusion inhibition had tissue construct sizes that were 68% of the initial, and these results 
were statistically significantly smaller (p < 0.05, as indicated by ‘*’) than both the anti-
cadherin and anti-integrin spheroids, which demonstrates that cell-cell and cell-matrix 
proteins do play a role in tissue fusion. However, significant differences were not 
observed between the influences of cadherins and integrins, which suggests that both 
cell-cell and cell-matrix interactions are involved in fusion and that other cell-cell and 
cell-matrix protein blockers still need to be tested. These results add to the understanding 
of the complex mechanisms behind tissue fusion and show the potential for future tissue 
fabrication experiments to be tailored using optimal spheroid formulations for rapid and 
complete tissue fusion. 
 
Figure 3.11. Influence of Cell-ECM and Cell-Cell Interactions on Spheroid Fusion. 
For studying cell-matrix interactions, the function of integrins was inhibited with an anti-
integrin functional grade antibody in fusing spheroids in capillary tubes. Results showed 
that spheroids with functional inhibition of integrins had tissue construct sizes that were 
85% of the initial sizes after 48 hours. Results demonstrated that spheroids with 
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functional inhibition of cadherins had tissue construct sizes that were 81% of the initial 
sizes after 48 hours. Control spheroids without fusion inhibition had tissue construct sizes 
that were 68% of the initial, and these results were statistically significantly smaller than 
anti-integrin and anti-cadherin spheroids (p<0.05, as indicated by ‘*’), which 
demonstrates that cell-matrix and cell-cell proteins do play a role in tissue fusion. 
 
3.4 DISCUSSION 
In this work, we have demonstrated that iron oxide MNPs stimulate the synthesis 
of collagen in cellular spheroids, when compared to no iron oxide control spheroids. This 
stimulation is perhaps due to the interactions of cells on the surface of the nanoparticles 
or release of iron ions during degradation in spheroid (20). Further, our results show that 
the influences of iron oxide on collagen synthesis are similar to that of ascorbic acid, a 
known collagen synthesis stimulant. Future work will include studying the influence of 
MNPs on collagen crosslinking and accelerating the maturation of tissues assembled with 
JMCSs.  
Bottom up engineering approaches, like cell sheet and cellular spheroid 
techniques, allow for control over the cell number and ECM content. However, the role 
of cell-cell and cell-ECM interactions on tissue fusion has not been fully understood. Our 
results demonstrate that the composition of the building block for tissue fabrication is 
critical because cell number and ECM content mediate the fusion process. The active 
fusion created from the physical magnetic forces increased cell-cell adhesions, which is 
perhaps mediated by increased cadherin interactions. This activity may lead to 
downstream intercellular and intracellular signaling that promotes fusion through cell 
migration and reorganization, ECM remodeling and cytoskeletal contraction. Future 
research must involve not only accelerating the fusion of tissues, but also studying the 
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deposition of other ECM proteins, like elastin and fibronectin, and the enhancement of 
mechanical properties.  
 Overall, our results show that it is not only the magnetic forces, but the 
composition of the spheroids used that is important to accelerate fusion of spheroids 
when they are exposed to magnetic forces.  Results from tissue ring and capillary studies 
show that ECM content plays a role in mediating tissue fusion, as higher collagen content 
decreases the rate of tissue fusion. While high collagen content spheroids may not 
provide for the most cell intermixing, as seen in Figure 7, it is critical for providing 
structural integrity of our tissue at later time points and when building larger tissues as 
shown in Figure 4 using rings. In previous work from our lab, fluorescently labeled high 
collagen tissue tubes that were fused for 24 hours showed minimal cell intermixing, as 
demonstrated by maintained spatial orientation of endothelial cell, smooth muscle cell 
and fibroblast layers. Our work presented here confirms that minimal cell intermixing is 
occurring at early timepoints between adjacent spheroids in capillary tubes. Dvir-
Ginzberg and coworkers showed that the cell number is critical to fabricating liver tissue 
constructs, as higher cell number spheroids led to increased viability and metabolic 
output, compared to lower cell numbers [157]. This indicates that using a physiologically 
relevant cell number is not only critical to tissue formation, but also in defining tissue 
functionality. Future work will include monitoring the cell number in individual 
spheroids and fusing spheroids over time, to understand how cell number influences the 
developing tissues. Our work has shown that the fusion process is regulated by cell-cell 
and cell-matrix interactions, as inhibition of cadherins and integrins led to less fusion 
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over time, when compared to untreated controls. Our work represents the begining in 
understanding how spheroid composition is critical for the fusion of spheroids into 
complex tissues mediated by magnetic forces. Using this information, more effective and 
applicable engineered tissues may be developed due to optimized predictions prior to 
assembly. 
 
3.5 CONCLUSIONS 
In conclusion, spheroid composition is critical to the fusion process and 
manipulation of the composition was utilized to study fusion kinetics of JMCSs mediated 
by magnetic forces. Results showed that ECM content and cell number play a key role in 
mediating the fusion of cellular spheroids into complex tissues. Results showed that iron 
oxide MNPs in JMCSs stimulate collagen production, which is critical for scaffold free 
tissue engineering. Further, results demonstrated that cell-cell and cell-ECM interactions 
in spheroids are critical in determining the fusion dynamics of tissues. This new 
understanding of JMCS composition and its influence on fusion can be applied to the 
fabrication of larger tissues, like blood vessels. This could be a change in paradigm when 
related to tissue engineering approaches because more collagen does not result in 
enhanced fusion. Future work will involve using magnetic forces to induce maturation of 
assembled tissue constructs, with a focus on enhancing ECM production and mechanical 
properties. 
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CHAPTER 4 
MATURATION OF TISSUES COMPOSED OF JANUS MAGNETIC CELLULAR SPHEROIDS 
4.1 INTRODUCTION 
 The three steps in bioprocessing of tissues using cellular spheroids are pre-
processing, processing and post-processing. The preparation of the spheroids to be used 
as the building blocks for tissue fabrication is known as pre-processing. The patterning of 
the cellular spheroids into the desired orientation and fusion of adjacent spheroids is 
known as processing. Tissue fusion is a process in which two or more distinct cell 
populations, or tissues, make contact and form a single cohesive structure over time [11, 
29, 34]. The post-processing step uses bioprocessing techniques, like mechanical 
stimulation, to mature the tissues over time. The goal of tissue maturation is to improve 
the mechanical properties, ECM contents and functionality of the developing tissues. 
Fabricating tissue that has suitable mechanical properties can take months, or more than a 
year, due to cell culturing time and long periods of post processing [26, 57].The 
underlying mechanisms of the processing and post-processing steps, which are critical to 
the development of tissue engineered constructs, are not yet clearly understood. 
Understanding and accelerating both, tissue fusion and maturation, is critical for 
producing tissue engineered construct on demand. 
 For vascular tissue applications, cyclic radial strain has been shown to enhance 
the strength of tissue engineered vascular mediums by 22-57% and increase collagen 
content by 22%, when compared to statically cultured controls [56, 83]. However, the 
parameters for optimal maturation (frequency, magnitude, time of stimulation) have not 
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been defined [56, 57, 82, 83, 85]. These studies overlook another force experienced by 
blood vessels, longitudinal stretch. Almost all arteries in vivo experience longitudinal 
strain (axial), with magnitudes ranging from 40% to 65% [162-166]. Local tissue growth 
or atrophy during development, weight gain/loss, pregnancy, parturition, sustained 
exercise programs, and pathological conditions will alter longitudinal forces experienced 
in vivo [162-164]. A study by Gauvin and coworkers suggests that tissue sheets 
composed of human dermal fibroblasts exposed to static and dynamic longitudinal strain 
experienced increased expression of type I collagen and elastin in western blot analysis 
when compared to static controls [81]. Additionally, the axial ultimate tensile strength 
increased by 1.856 fold when compared to statically cultured tissues and the axial 
modulus increased by 1.724 fold when compared the statically cultured tissues. Further, 
this same study showed that tissues exposed to static and dynamic longitudinal strain 
experienced preferential cellular and ECM alignment parallel to the axis of the forces 
applied. Han and coworkers studied the effect of longitudinal stretch on vascular function 
and wall remodeling using porcine carotid arteries [166]. Vessels were stretched 20% 
more than in vivo for five days in a bioreactor system under pulsatile flow at 
physiological pressure. For both, stretched and control vessels, results demonstrated high 
viability using an MTT assay and ethidium-positive cell counting. Both groups 
demonstrated significant contractile response to norepinephrine (10% diameter 
contraction) [166]. The results of a BrdU proliferation assay indicated that longitudinal 
stretching promotes cell proliferation, while maintaining arterial function [166].  
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 Scaffold-free cellular aggregates, or tissue spheroids, mimic the 3D orientation of 
native tissue and produce their own extracellular matrix over time, making them 
attractive for tissue fabrication [11, 29, 34, 48]. Magnetic nanoparticles (MNPs) have 
been incorporated into cellular spheroids for alignment and patterning of tissues mediated 
by magnetic forces [36, 76-78, 88, 90, 92, 93, 97, 122, 151, 152], but the use of magnetic 
forces for accelerating maturation of vascular constructs has not been studied. Previously, 
magnetic forces have been used to mature bone constructs, demonstrating the potential of 
inducing desired differentiation and increased ECM production within 1 to 3 week 
treatment times [130, 131]. The rationale is that magnetically induced mechanical 
stimulation of the MNP containing tissues should cause preferential alignment of cells 
and deposition of ECM in response to the applied magnetic forces. Magnetic force 
technologies are attractive for tissue engineering applications because they allow for 
precise and controlled manipulation of the tissues at a distance with magnetic fields [36, 
76-78, 91, 113, 122, 125, 167].  
 In this work, we present the use of magnetic forces for mechanical maturation of 
tissues composed of Janus Magnetic Cellular Spheroids (JMCSs) for vascular tissue 
applications. The Janus method of spheroid fabrication allows for the creation of 
separation between cells and extracellular MNPs, while maintaining cell viability, 
functionality and phenotypic expression over time [37, 76-78, 122]. The objective of this 
work is to investigate the effects of magnetic forces on tissues composed of JMCSs with 
respect to ECM deposition and mechanical properties over time. The hypothesis driving 
this research is that magnetic forces can mechanically stimulate tissues composed of 
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JMCSs to stretch the tissues in a controlled, cyclic uniaxial longitudinal direction to 
induce maturation over time. The rationale is that if magnetic forces can mediate the 
maturation of the tissue engineered construct composed of JMCSs, then the mechanical 
properties and ECM deposition within the developing tissue can be improved over time 
when compared to statically cultured tissues. To our knowledge, we are the first group to 
test cyclic longitudinal stretching mediated by magnetic forces to accelerate the 
maturation of tissues composed of JMCSs. Understanding how magnetic forces facilitate 
the maturation of tissues composed of JMCSs over time could provide the foundation for 
fabricating tissues tailored to specific applications. 
4.2 MATERIALS & METHODS 
 An overview of experimental procedures, parameters, and objectives can be found 
in Table 4.1. 
 Table 4.1. Experimental Plan for Maturation of Tissues Composed of JMCSs 
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Cell Culture 
 For this work, primary rat aortic smooth muscle cells (SMCs) were isolated from 
the aorta via careful removal of the adventitia and endothelial cell lining, followed by a 
one hour incubation with trypsin (0.25%) and collagenase (5 units/mL). Passage numbers 
under ten were used. SMCs were cultured in monolayers at 37 °C and 5% of CO2 until 
spheroid assembly. SMCs were cultured using Dulbeco’s Modified Eagle Medium:F-12 
(ATCC, 1:1, DMEM:F-12) supplemented with 10% fetal bovine serum (Atlanta 
Biologics) and 1% penicillin-streptomycin-amphotericin (MediaTech, Inc.). 
 
Spheroid Formation 
 Spheroids were prepared using a method previously described and developed in 
our lab [76-78]. Our lab has developed a Janus structure of magnetic cellular spheroids 
(JMCS) and this provides spatial control of magnetic nanoparticles (MNPs) to create two 
discrete domains: extracellular MNPs and cells[78]. Uniform volumes of solutions 
comprised of suspended iron oxide MNPs (Fe3O4, 20-30 nm, SkySpring Nanomaterials, 
Inc., Texas, USA), collagen (Bovine, Type I, Life Technologies, California, USA), and 
cells in cell culture media were mixed and dispersed onto petri dishes using the hanging 
drop technique into 15 μL droplets. For these studies, spheroids were fabricated with 
20,000 cells each. Primary rat aortic smooth muscle cells were used for the tissue samples 
presented in this work. Spheroids were left to form for three days prior to use. Collagen 
was prepared according to the recommendations of the manufacturer and kept on ice 
before use in all samples. For long term studies, spheroids were placed into non-tissue 
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culture treated 96 well plates in the presence of cell culture media, with or without 
ascorbic acid supplementation (50 μg/mL). 
 
Tissue Sheet Fabrication 
 Monolayer sheets composed of JMCSs were assembled using a strip of magnets 
(2.5 mm outer diameter, 5 mm length, K&J Magnetics, Inc., Pennsylvania, USA). Five 
magnets were attached to the underside of a 6 well plate (Greiner Bio-One, North 
Carolina, USA) and a glass cover slip (micro cover glass 22x30 mm, VWR, 
Pennsylvania, USA) was positioned directly over the magnets within the well plate to 
prevent spheroid adherence to the well plate. The wells were filled with cell culture 
media and 1,000 JMCSs of the same formulation were carefully aligned on the coverslip 
using a pipette tip and incubated at 37°C and 5% CO2 for 3 days to allow fusion to occur. 
 
Collagen Quantification 
 The collagen content in the media that was produced by the tissue sheets was 
determined using a hydroxyproline assay, as previously described [153]. First, the media 
was collected, frozen and then lyophilized. Samples were hydrolyzed in 4N sodium 
hydroxide at 120˚C for 2 hours. Samples were neutralized with 1.4N citric acid and pH 
balanced to a range of 7.2 to 7.6. A hydroxyproline standard curve was prepared for 
calibration of unknown samples. An aliquot of 200 µL was taken from each sample to be 
incubated with a Chloramine T solution for 15 minutes and then a p-
Dimethylaminobenzaldehyde solution for 15 minutes at 65˚C. Next, experimental 
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samples were prepared as triplicates for optical number readings at 550 nm. Unknown 
samples were calculated based on the hydroxyproline standard curve. Day 3 and 7 
samples were normalized to each respective group’s collagen content at Day 1. 
 
Maturation with Magnetic Forces 
 After ten days of fusion, the magnetic templates underneath the well plates 
containing the fused magnetic cellular sheets were removed. The wells containing the 
fused magnetic cellular sheets were placed onto a platform inside an incubator set at 37˚C 
and 5% CO2. A rod magnet (30 mm) composed of stacked cylinder magnets (2.5 mm 
diameter, 5 mm length, pull force =1.8 lbs, SuperMagnet Man) was placed directly 
underneath each magnetic cellular sheet on the platform. The platform containing the rod 
magnets was fixed to a linear actuator (L16-P Linear Actuator, Firgelli, Victoria BC, 
Canada) that was controlled using a custom program built in LABVIEW (National 
Instruments). This custom program allowed for controlled cyclic longitudinal translation 
of the rod magnets to provide cyclic longitudinal stretch of the magnetic cellular sheets. 
Through the program, the frequency, magnitude and time of stretch was controlled. For 
this work, 1 Hz and 10% were the frequency and magnitude, respectively. Tissue sheets 
were grouped as follows: 3 days of static conditioning on the magnetic template, 7 days 
of static conditioning on the magnetic template, 3 days of dynamic longitudinal stretching 
using magnetic forces and 7 days of dynamic longitudinal stretching using magnetic 
forces. 
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Histological Examination 
 At different time points, spheroids and tissue sheets were collected, fixed and 
processed for histological examination [122]. Tissues were embedded into paraffin and 
samples were cut into 5 μm sections. Samples were stained using either hematoxylin and 
eosin (H&E) or Masson’s Trichrome stain. 
 
Immunohistochemistry 
 At different time points, spheroids and tissue sheets were collected, fixed and 
processed for histological examination [122]. Tissues were embedded into paraffin and 
samples were cut into 5 μm sections. Four ECM markers were analyzed: Collagen I, 
Collagen IV, Fibronectin and Elastin. The following antibodies were used to stain for 
these markers: anti-collagen I antibody (1:200; abcam; ab34710), anti-collagen IV 
antibody (1:200; abcam; ab6586), anti-fibronectin (1:200; BD Biosciences; 610077), and 
anti-elastin (1:50; abcam; ab23748). Prepped slides were analyzed using a BOND-MAX 
automated IHC machine (Leica). An automated Novocastra Bond Polymer Refine 
Detection system (Leica; DS9800) was used to stain and detect protein markers in the 
tissue samples. Stained samples were imaged using a Nikon AZ100 multizoom 
microscope. Results were compared to respective control samples that were only 
counterstained for nuclei. Positive protein expression was quantified by measuring the 
percent area of the tissue expressing a positive stain and then normalizing to the total area 
of the spheroid. 
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Western Blot for Collagen and Elastin Protein Quantification 
 Tissue sheets were collected after 3 and 7 days with and without longitudinal 
stretch by magnetic forces. Sheets were then flash frozen for storage. Samples were 
placed in lysis buffer and sonicated to extract protein. Protein content was quantified 
using spectroscopy and each sample was loaded into gels at 10 µg/well. For primary 
antibodies, rabbit polyclonal antibody against collagen I was used to detect collagen I 
content (Abcam, ab34710), mouse monoclonal antibody against Hsp47 was used to 
detect Hsp47 content (Calbiochem, M16.10A1) and mouse monoclonal antibody against 
elastin was used to detect elastin content (Santa Cruz Biotechnology, sc-374638). Bands 
were detected by chemiluminescence using peroxidase-conjugated horseradish secondary 
antibodies with Amersham’s ECL Prime Western Blotting Detection Reagent. Protein 
band intensities were quantified using ImageJ. 
 
Collagen Fiber Alignment 
 Collagen fiber alignment was performed by measuring the angle of 50 collagen 
fibers with respect to the axis of the applied magnetic cyclic longitudinal forces. 
 
Mechanical Testing with Atomic Force Microscopy 
 After 3 and 7 days, atomic force microscopy (AFM) (Asylum MFP-3D on top of 
an Olympus IX81 Spinning Disc Confocal system) was used to determine the Young’s 
modulus of statically and dynamically conditioned tissue sheets. A cantilever (~0.12 N/m 
spring constant) with a borosilicate spherical tip (5 µm diameter) was used to indent 
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tissue sheet samples. The cantilever deflection was measured and converted to a force 
measurement using the respective Hook’s spring constant of the tip. The Hertz Model 
was used to calculate the Young’s modulus from force-distance curves during data 
analysis (MATLAB). Three repeats were used for statistical significance and to confirm 
repeatability.  
 
Statistical Analysis 
Statistical analysis was performed using an Analysis of Variance (ANOVA) test 
to determine if differences were present amongst treatment groups. If differences were 
determined from the ANOVA, a post hoc two tailed t-test was used to determine if 
significant differences existed between treatments tested. Error bars on graphs represent 
the standard deviation from the mean. 
 
4.3 RESULTS 
4.3.1 MATURATION OF SPHEROIDS OVER TIME 
 JMCSs and no iron oxide (NIO) spheroids were formed for three days using 
primary rat aortic smooth muscle cells with the hanging drop method [78]. Previous work 
and immunohistochemical staining demonstrated that NIO spheroids and JMCSs had the 
same ECM contents after three days of formation [37]. Spheroids were incubated for 40 
days in cell culture media, with and without ascorbic acid supplementation (50 μg/mL). 
Ascorbic acid is a known stimulant of collagen production over time and was used as a 
control for our spheroids with and without MNPs. Samples were processed, sectioned and 
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immunohistochemically examined after 40 days of incubation [122]. Results 
demonstrated that each spheroid type stained positive for collagen I, collagen IV, elastin 
and fibronectin ECM proteins when compared to control samples (Figure 4.1a). After 40 
days, spheroids are organized, as depicted by their well-defined spherical shape and 
cellular organization (Figure 4.1a). The positive expression area of these protein markers 
in day 40 spheroids was quantified using ImageJ and normalized to the respective total 
area of the tissues (Figure 4.1b). Statistical analyses were not used because only one 
sample was analyzed per group for each antibody to confirm expression of the respective 
vascular protein. Results demonstrated that the NIO and JMCS D3 spheroids had 
comparable positive expression area of collagen I and elastin when compared to day 40 
time points, with positive expression areas of 61.96 and 70.84 for NIO day 3 and 57.62 
and 68.58 for JMCS day 3 (data not shown). At early time points, while spheroids are 
still forming, cells are secreting more protein, protein precursors and ECM components 
that can be used to build ECM in attempt to establish structural stability. Collagen and 
elastin are critical for this function. As spheroids mature over time, ECM becomes 
aligned, deposited and organized according to the systemic needs of the tissue. Over time, 
spheroids optimize their structure and do not rapidly secrete proteins and their precursors, 
like at earlier time points, because they become structurally stable without the presence of 
physical forces or environmental cues [11, 29]. This is the cause for the small increase or 
drop in positive area of protein expression in day 40 spheroid for collagen and elastin, 
when compared to day 3. Interestingly, there was an increase in positive area of protein 
expression in all groups for collagen IV and fibronectin when comparing day 40 
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spheroids to day 3 spheroids. Collagen IV, in addition to collagen I, has been shown to be 
important for structural stability in vascular tissue and fibronectin is critical for cell 
adhesion, ECM attachments and cell proliferation during maturation of tissue [168, 169]. 
An increase in collagen IV and fibronectin expression in spheroids over time would be 
expected to accommodate the needs for structural stability and organization as the tissue 
develops and matures over time [170].  
 Further, the positive area stains observed in JMCSs spheroids at day 40 were 
comparable to the NIO group supplemented with ascorbic acid, which is a known 
stimulant of ECM production [26, 171, 172]. Additionally, JMCSs supplemented with 
ascorbic acid had higher expression of all proteins at the day 40 time point, suggesting a 
synergistic effect between iron oxide MNPs and ascorbic acid for ECM production. This 
corresponds to our previous work where iron oxide MNPs were shown to stimulate ECM 
production over time, when compared to spheroids without iron oxide MNPs and 
spheroids without iron oxide MNPs supplemented with ascorbic acid [37]. While 
ascorbic acid has been known to enhance collagen production through ascorbate-
dependent hydroxylation, its effect on elastin is not completely understood. A study in 
1980 by de Clerck and coworkers used 2D cultures of smooth muscle cells and showed 
that the deposition of insoluble elastin was inversely proportional to ascorbic acid 
concentration due to over hydroxylation of tropoelastin, which is the precursor to 
insoluble elastin [171, 173]. In 2013, a study by Derricks and coworkers observed a 
dramatic increase in elastin production from primary rat neonatal pulmonary fibroblasts 
in response to ascorbic acid in 3D cell-Gelfoam constructs [174]. From day 14 to 21, 
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ELISA results showed that elastin deposition increased 4.5 fold in the ascorbic acid 
treated 3D cell-Gelfoam constructs when compared to no ascorbic acid treated tissues 
[174]. q-PCR results supported these results as protein expression increased from 1.5 fold 
to 8.8 fold over the same time period for ascorbic acid treated tissues [174]. At the same 
time, no significant elastin deposition was observed in 2D cultures of the same cell type 
over time [174]. These results indicate that the 3D nature of the cell-ECM environment 
will direct the cellular response to ascorbic acid. While ascorbic acid has not been shown 
to significantly induce elastin production in 2D cultures of smooth muscle cells, here we 
have shown that cellular spheroids, which are 3D cell cultures, will respond to treatment 
with ascorbic acid (50 μg/mL). Based on work by Derricks and coworkers, we can 
attribute the cellular response in the spheroids from ascorbic acid to the 3D architecture 
of the spheroids.  
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Figure 4.1. Immunohistochemistry Staining of Spheroids Over Time. (a) Spheroids containing 
iron oxide MNPs and spheroids without MNPs were immunohistochemically examined for 
collagen I, collagen IV, elastin and fibronectin after 40 days of incubation in cell culture media. 
Spheroids with and without MNPs were also incubated in media supplemented with ascorbic acid, 
a known stimulant of collagen production. When compared to their respective controls, each 
spheroid type demonstrated positive stains for each ECM marker. Day 40 spheroids have 
demonstrated preferential cellular organization, given by the spherical geometry. (b) Positive 
expression area of collagen I, collagen IV, elastin and fibronectin was quantified using ImageJ and 
normalized to respective control tissues. (NIO=No iron oxide spheroids; JMCS=Janus magnetic 
cellular spheroids; AANIO=Ascorbic acid no iron oxide spheroids; AAJMCS=Ascorbic acid janus 
magnetic cellular spheroids). 
 
a 
b 
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 In previous work, we have demonstrated that vascular smooth muscle cells 
maintain viability and cellular phenotype when formed into JMCSs [78]. When combined 
with long term viability, positive expression for vascular ECM markers over 40 days is a 
critical step for the development of viable and functional tissue engineered constructs. 
Future work will include additional time points to thoroughly characterize the 
development of the ECM network in developing spheroids. Further, ECM production will 
be studied in spheroids composed of fibroblasts and endothelial cells, which can lend 
insight into the role and importance of communication between the different vascular cell 
types. 
4.3.2 DYNAMIC AND STATIC MATURATION OF TISSUE SHEETS 
Tissue Sheet Histological Examination and ECM Production 
 Multiple groups are utilizing spheroids to build larger and more complex tissues 
for various applications [11, 12, 38, 59, 69, 136, 175, 176]. Magnetic force based tissue 
engineering is an attractive option for biofabrication because tissues can not only be 
patterned and aligned from a distance, but also their fusion accelerated over time due to 
increased contacts created due to the magnetic forces [36, 76-78, 122, 125]. Here, 
magnetic forces were used to pattern JMCSs into tissue sheets and to promote their fusion 
over time by promoting active contact between adjacent spheroids (Figure 4.2a). After 
10 days of fusion, tissue sheets were either statically maintained on a magnetic template 
or dynamically conditioned using cyclic longitudinal stretch mediated by magnetic forces 
(Figure 4.2b). A custom program, built using LABVIEW, allowed for precise control 
over the frequency, magnitude and time of conditioning. 
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Figure 4.2. Processing and Post-Processing of Tissue Sheets Composed of 
JMCSs. (a) Schematic depicting tissue sheet processing. 1,000 JMCSs were 
formed for three days using the hanging drop method. Spheroids were then 
seeded into a 6 well plate with a glass slide on the inside bottom surface. 
Magnets attached to the bottom of the 6 well plate allow for patterning of the 
spheroids into a rectangular sheet. Sheets were allowed to fuse for 10 days. 
(b) Schematic depicting tissue sheet post-processing. The magnetic templates 
were removed from the bottom of the well plates containing fused tissue 
sheets. The well plates containing the fused sheets were placed onto a 
platform inside an incubator. Using a linear actuator, an array of magnets was 
translated in a cyclic, uniaxial direction beneath the fused tissue sheets. The 
device allows for precise control over frequency, magnitude of stretch and 
duration of conditioning. 
 Gauvin and coworkers cultured tissue sheets using a self-assembly approach over 
35 days with dermal fibroblasts supplemented with ascorbic acid. The tissue engineered 
sheets were dynamically conditioned using cyclic longitudinal strain using 1 Hz 
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frequency, 10% magnitude and 72 hours of conditioning. When compared to statically 
cultured tissues, dynamically conditioned tissues demonstrated increased collagen I and 
elastin production using western blot. Additionally, the axial ultimate tensile strength 
increased by 1.856 fold when compared to statically cultured tissues and the axial 
modulus increased by 1.724 fold when compared the statically cultured tissues. To be 
consistent with the literature and to simulate physiological conditions, our study used 1 
Hz, 10% and 24 hours per day as the chosen frequency, magnitude and time of 
conditioning, respectively. 
 Here, tissues sheets were collected for analysis after 3 and 7 day time points. 
Histological examination using an H&E stain demonstrates the presence of cell nuclei 
throughout statically and dynamically conditioned sheets at the 3 and 7 day time points 
(Figure 4.3). In previous work, live/dead staining demonstrated that the tissue sheets 
contain a large population of viable cells with only a small portion of dead cells after 3 
days of fusion. The Masson’s Trichrome stain demonstrates the presence of collagenous 
ECM throughout the statically and dynamically conditioned groups after 3 and 7 days 
(Figure 4.3). Results demonstrate that aligned collagenous fibers along the stretching 
direction are visible in the tissue sheets that were dynamically conditioned for 7 days, 
which indicates that the cyclic longitudinal conditioning mediated by magnetic forces is 
causing ECM remodeling in response to the dynamic forces applied. The development of 
a cross-linked collagenous network is critical for the success of a scaffold free tissue 
engineered construct, as it provides for structural integrity and acts as a scaffold for 
cellular organization [57, 154, 165, 177]. Iron has been shown to effect collagen on the 
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cellular level by up-regulating collagen gene expression and also at the extracellular level 
by promoting and stabilizing collagen crosslinking [155]. Here, the dynamic conditioning 
of the tissue sheets mediated by magnetic forces is providing the cues for maturation. 
Additionally, the ions being released from the degradation of the iron oxide MNPs inside 
the tissue sheets over time could be up-regulating collagen production and promoting 
crosslinking of collagen produced by the tissues.  
Figure 4.3. Tissue Sheet H&E and Masson’s Trichrome Staining. Fused tissue sheets 
composed of JMCSs were either statically maintained on a magnetic template or dynamically 
conditioned using magnetic forces. After 3 and 7 day time points, tissue sheets were collected, 
fixed and processed for histological examination. The H&E stain demonstrates the presence of 
cell nuclei throughout the statically and dynamically conditioned groups after 3 and 7 days. The 
Masson’s Trichrome stain demonstrates the presence of collagenous ECM throughout the 
statically and dynamically conditioned groups after 3 and 7 days. 
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 Results of immunohistochemical staining demonstrate that tissue sheets produce 
ECM over time, as statically and dynamically conditioned tissue sheets stained positive 
for collagen I, collagen IV, elastin and fibronectin at day 3 and day 7 time points (Figure 
4.4a). The positive expression area of these protein markers in day 7 tissue sheets was 
Figure 4.4. Tissue Sheet Immunohistochemistry Staining. (a) Fused tissue sheets 
composed of JMCSs were either statically maintained on a magnetic template or dynamically 
conditioned using magnetic forces. After 7 days, tissue sheets were collected, fixed and 
processed for histological examination. When compared to the control tissue samples, static 
and dynamic tissues all stained positive for collagen I, collagen IV, elastin and fibronectin. 
(b) Positive expression area of collagen I, collagen IV, elastin and fibronectin was quantified 
using ImageJ for day 7 statically and dynamically conditioned tissues.  
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quantified using ImageJ and normalized to the respective total area of the tissues (Figure 
4.4b). Statistical analyses were not used because only one sample was analyzed per group 
for each antibody to confirm expression of the respective vascular protein. For statically 
conditioned tissue sheets, results showed positive expression areas of 70%, 73%, 13%, 
and 41% for collagen I, collagen IV, elastin and fibronectin, respectively. Results 
demonstrated that dynamically conditioned tissue sheets had positive expression areas of 
75%, 75%, 20% and 41% for collagen I, collagen IV, elastin and fibronectin, 
respectively. Dynamic conditioning did not increase collagen production based on IHC 
studies, as the statically conditioned tissues demonstrated comparable levels of 
expression. These results are consistent with spheroid studies, where there was high 
expression of collagen I, collagen IV, fibronectin and increased expression of elastin. 
Expression of these proteins after the spheroids have been patterned and fused into tissue 
sheets demonstrates that the tissue sheet processing step stimulates production of these 
key vascular ECM proteins. 
 Dynamic mechanical conditioning has been used to induce collagen and elastin 
production in 2D cultures and 3D tissue constructs [56, 81, 82, 178]. Gauvin and 
coworkers used cyclical longitudinal stretching to induce anisotropy and improve tensile 
properties of engineered tissues constructed with human dermal fibroblasts. Histological 
examination confirmed organized collagen and western blot confirmed the presence of 
collagen and elastin content within the tissues, but this was not quantified. Here, cyclical 
longitudinal stretching, mediated by magnetic forces, of tissue sheets composed of 
primary rat aortic smooth muscle cells was used to induce collagen and elastin production 
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as a post-processing technique for maturation. Western blot was used to probe for 
collagen I, Hsp47 and elastin content in the tissue sheets. For this study, one western blot 
was performed to confirm protein content and gain an understanding of the relative 
protein contents. When compared to day 3 static sheets, results demonstrated a 2.40 fold 
increase in collagen content for day 7 static sheets, a 3.03 fold increase in collagen 
content for day 3 dynamic sheets and a 3.09 fold increase in collagen content for day 7 
dynamic sheets (Figure 4.5a). Heat shock protein 47 is a collagen binding glycoprotein 
localized in the endoplasmic reticulum and is a chaperone that mediates collagen 
maturation [179]. When compared to day 3 static sheets, results showed a 1.10 fold 
increase in Hsp47 content for day 7 static sheets, a 4.84 fold increase in Hsp47 content 
for day 3 dynamic sheets and a 8.50 fold increase in Hsp47 content for day 7 dynamic 
sheets (Figure 4.5a). When probed for elastin and compared to day 3 static sheets, results 
showed a 1.15 fold increase in elastin content for day 7 static sheets, a 20.4 fold increase 
in elastin content for day 3 dynamic sheets and a 35.3 fold increase in elastin content for 
day 7 dynamic sheets (Figure 4.5a). The respective protein bands from the western blots 
are depicted in Figure 4.5b. These results indicate that the dynamic longitudinal 
stretching, mediated by magnetic forces, caused an increase in collagen production over 
time when compared to statically cultured controls. Future work will include quantifying 
collagen cross-linking, analyzing ECM gene expression of tissues that are dynamically 
conditioned and including longer time points. 
 O’Callaghan and coworkers dynamically stretched VMCSs 10%-16% of the 
original length for 5 days at 1 Hz and results demonstrated that collagen production in 
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media was 12% for statically conditioned cells and 18% for dynamically conditioned 
cells [178]. Dynamic conditioning of cell sheets composed of neonatal dermal fibroblasts 
actually showed less collagen production (% of total protein) when compared to statically 
cultured tissue sheets (10% stretch vs. 13% static), but no differences in collagen 
concentration. Here, total collagen content was quantified at days 1, 3 and 7 in the media 
collected from statically and dynamically cultured tissue sheets (Figure 4.5c). When 
normalized to day 1, day 3 and day 7 statically conditioned tissue sheets had collagen 
contents that were 99% and 94%, respectively. For dynamically conditioned tissue sheets, 
collagen contents at the day 3 and 7 time points were 110% and 113%, respectively, 
when normalized to day 1. At the day 3 and day 7 time points, the dynamically 
conditioned tissues had significantly higher collagen contents than the static controls 
(p<0.05). These results support that dynamic conditioning mediated by magnetic forces is 
inducing collagen production and reorganization. 
a b 
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Figure 4.6. Tissue Sheet Mechanical Properties. The Young’s modulus tissue sheets 
were determined using atomic force microscopy. Results demonstrate that the 
dynamically conditioned tissue sheets had significantly higher Young’s modulus values 
at both time points when compared to statically conditioned controls. (‘*’ and ‘+’ indicate 
statistical significance). 
b 
a 
a 
Figure 4.5 Insoluble and Soluble Protein Content in Tissue Sheets. (a) Quantification of 
collagen I, Hsp47 and elastin content in tissue sheets with and without cyclic longitudinal 
stretching mediated by magnetic forces. Results are normalized to day 3 static tissue sheets. 
(b) Representative protein and GAPDH bands from western blots. (c) Normalized soluble 
collagen content in the media of statically and dynamically conditioned tissue sheets after 3 
and 7 days. (‘*’ and ‘+’ indicate statistical significance). 
c 
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Tissue Sheet Mechanical Properties  
 The Young’s modulus of tissue sheets that were subjected to cyclic longitudinal 
stretching mediated by magnetic forces were compared to statically maintained tissue 
sheets at 3 and 7 day time points. Here, 1 Hz frequency, 10% magnitude and 24 hours per 
day stretching were used as the conditions based on physiological demands [2, 81, 82]. 
Results demonstrate that the day 3 dynamically conditioned tissue sheets had a Young’s 
modulus (32 kPa) that was significantly greater than its statically conditioned counterpart 
(22 kPa) (Figure 4.6). Results also show that the day 7 dynamically conditioned tissue 
sheets had a Young’s modulus (39 kPa) that was significantly greater than its statically 
conditioned counterpart (27 kPa) (Figure 4.6).  
 
Fiber Alignment in Tissue Sheets 
 Physiologically, elastic fibers and contractile SMCs are responsible for vascular 
mechanical strength and linear elastic behavior at low pressures [165]. Aligned collagen 
fibers are heavily recruited at greater than physiological blood pressures. At these levels, 
the collagen fibers cause a non-linear stress-strain relationship and are responsible for the 
high ultimate tensile strength, stiffness, and elastic modulus observed in native arteries 
[3, 57, 165, 180]. Here, collagen fiber alignment was observed in the direction of the 
applied magnetic cyclic longitudinal stretching forces for day 7 samples when compared 
to day 3 statically conditioned samples (Figure 4.7a). To quantify collagen fiber 
alignment, the angle of the fibers with respect to the applied force was measured. Results 
demonstrated that 37 of the 50 collagen fibers measured had angles that were within 10 
c 
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degrees of the axis of the applied magnetic force, demonstrating fiber alignment from the 
dynamic magnetic force maturation (Figure 4.7b).  
 
 
 
 
 
Figure 4.7. Collagen Fiber Alignment. (a) After 7 days of cyclic longitudinal 
stretching mediated by magnetic forces, collagen fibers were observed, when 
compared to 3 days of static conditioning. (b) The angle of 50 collagen fibers was 
measured with respect to the applied magnetic forces and results showed that 37 of 
the 50 fibers measured were within 10 degrees of the axis of the applied forces. 
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4.4 DISCUSSION 
 Recently, cellular spheroids have been employed to biofabricate vascular 
constructs, due to their ability to produce ECM over time and their three dimensional 
nature, which more accurately mimics native tissues. When developing a tissue 
engineered vascular construct, it will be essential that the tissues contain key vascular 
ECM proteins like collagen I, collagen IV, elastin and fibronectin [180].  These proteins 
are important for structural integrity, cellular organization and functionality of the tissues. 
Collagen I is present in all layers of blood vessels and is critical for stability of tissues 
[170]. It has a high tensile strength and elastic modulus to handle forces above 
physiological conditions. Mutations of genes affecting the col1 gene results in diseases 
like osteogenesis imperfecta and Ehlers-Danlos Syndrome Type VIIA and B [170]. 
Collagen IV is a major structural protein of basement membranes and over time will form 
the structural skeleton of the developing tissue [170]. Elastin is distensible and provides 
elasticity to distribute stress throughout vessel walls and collagen fibers. Fibronectin is 
essential in vessel development and plays a critical role in facilitating cell movement 
during early migratory events in cell wall formation [170]. Fibronectin’s continued 
expression over time during maturation suggests its importance in maintaining tissue 
homeostasis [170]. Our immunostaining results suggest continued expression of all these 
key vascular proteins in both individual spheroids and tissue sheets over time. Moreover, 
there seems to be a synergistic effect between iron oxide magnetic nanoparticles and 
ascorbic acid for ECM production in individual spheroids, which was previously 
observed using a hydroxyproline assay [37]. 
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 The mechanical properties of native arteries and veins are known and maturation 
methods have been used to develop tissues that mimic those mechanical properties [4, 56, 
57, 82, 181]. Scaffold free fabrication methods using spheroids and tissues composed of 
spheroids are expected to have lower mechanical properties due to the need of 
endogenous production of ECM. Mechanical analysis of human mesenchymal stem cell 
spheroid demonstrated that the incorporation of gelatin microparticles into spheroids 
yielded an average modulus that was more than 4 times greater than spheroids without 
microparticles, which can play a role in in vitro directed differentiation strategies [182]. 
Our results indicate that the cyclic longitudinal stretching mediated by magnetic forces 
provided the mechanical cues necessary to stimulate cell and ECM remodeling and 
reorganization according to the loads applied. 
 Further, dynamic conditioning was shown here to increase collagen, Hsp47 and 
elastin production during the 7 day period study using western blot. While only one 
western blot was performed for each protein, results suggest dynamic conditioning is 
causing the increase in protein content. This is the first known report of using magnetic 
forces to induce maturation in tissue sheets that includes collagen and elastin production. 
Western blot data showed that the GAPDH content for statically cultured tissues is lower 
than dynamically conditioned tissues. These results suggest that when compared to 
statically maintained tissue sheets, dynamic conditioning may be playing a role in 
maintaining expression of this key housekeeping protein that regulates glycolysis, 
transcription and nuclear function in the cells of the tissue sheets. Future work will 
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include western blot repeats for statistical significance and to quantify other key vascular 
protein contents. 
 In addition to enhancing protein content, the dynamic conditioning induced 
collagen crosslinking based on the appearance of aligned fibers. The alignment of the 
collagen fibers was a factor in the increased modulus of elasticity that was observed from 
dynamic longitudinal stretching. Weidenhamer and coworkers demonstrated collagen 
fiber alignment in tissue sheets composed of neonatal dermal fibroblasts that were 
subjected to 5% strain, 0.5 Hz for 3 weeks [183]. Stretched tissue sheets observed axial 
alignment of actin and collagen with fibers being all fibers being within 15 degrees of the 
axis of applied strain [183]. Gauvin and coworkers also observed alignment of collagen 
and actin in stretched tissue sheets, further demonstrating the use of mechanical 
stretching for the alignment and organization of ECM [81]. 
 In our previous work, it has been show that these tissue sheets, composed of fused 
JMCSs, can be wrapped around a silicone mandrel to form a tissue tube during the 
processing step [78]. Understanding the mechanics of spheroids and tissue constructs 
made from spheroids during the post-processing step will be important moving forward. 
Continuing to develop post-processing methods and understanding the mechanisms 
behind them will allow for tissue engineered constructs composed of spheroids to become 
comparable to native tissues in terms of mechanical properties and ECM content. Future 
work will include burst pressure and suture retention strength testing on tissue tubes that 
will be mechanically conditioned using magnetic forces. Post-processing conditions will 
be varied in terms of frequency of stimulation, magnitude of stretch and time. 
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4.5 CONCLUSIONS 
 Developing post-processing methods for enhancing ECM deposition and 
mechanical properties of tissues composed of cellular spheroids will be critical in order to 
be functional tissue engineered constructs. We demonstrated that over 40 days, JMCSs 
will continue to express collagen I, collagen IV, elastin and fibronectin, which are key 
vascular ECM proteins. Further, tissue sheets composed of JMCSs will continue to 
produce these key proteins, indicating that the tissue processing step into sheets may 
enhance ECM production. Quantitative results demonstrate that cyclic longitudinal 
stretching of the tissue sheets mediated by magnetic forces enhances the stiffness of the 
tissues over time, enhances collagen and elastin production, and collagen alignment in 
response to the forces applied. These studies highlight the use of magnetic force based 
tissue engineering and validate its potential for biofabrication methods. 
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CHAPTER 5 
CONCLUSIONS 
Overview 
 The work in this thesis demonstrates that spheroid composition and magnetic 
forces are critical to the fusion of spheroids over time. This research is significant 
because we developed new methods to safely integrate nanotechnologies with tissue 
engineered vascular tissue to accelerate fusion and maturation in a unique manner using 
magnetic forces. This work took advantage of two emerging areas in research—
nanotechnology and tissue engineering. The results from this work are expected to lead to 
an understanding of what conditions and cues are necessary to accelerate the fusion and 
maturation of tissues using physiological forces. Further, this could be a change in 
paradigm when related to tissue engineering approaches because we showed that more 
collagen does not result in enhanced fusion. This fundamental understanding is expected 
to provide a strong theoretical and methodological foundation for the development of 
new tissue engineering technologies with vascular tissue engineering applications. 
 
Limiting Magnetic Nanoparticle Interaction with Cells Using the Janus Method 
 A variety of methods that utilize internalization of MNPs into cells have been 
investigated to integrate MNPs with tissue engineering, including MNP 
conjugation/binding to the cell [89, 92, 93], cellular internalization [98, 114-116], and 
mixing MNPs within the ECM [88, 114, 117].  However, all of these approaches are 
limited to short term studies due to adverse effects related to MNP internalization [88-90, 
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116, 121] into cells. For this research, a novel method to incorporate iron oxide magnetic 
nanoparticles into cellular spheroids was used, called the Janus method, which was 
developed in our lab (Figure 5.1). This technology is innovative because upon spheroid 
fabrication, two separate domains are created: cells and MNPs. The limited interaction 
between cells and MNPs allows high viability and phenotypic expression to be 
maintained over time, which is essential for tissue engineering applications [37, 76-78]. 
Further, our research has shown that these Janus magnetic cellular spheroids are 
candidates for tissue engineering larger constructs [37, 77].  
 
 A limitation of using MNPs in tissue engineered constructs is the uncertainty of 
the influences and fate of iron oxide MNPs over time. Work has shown that excess 
amounts of iron in the body can cause disorders such as thalassemias, hemochromatosis, 
anemia and fibrosis [184]. To address these issues, work in our lab has been underway to 
Figure 5.1. Incorporating Iron Oxide MNPs into Cellular Spheroids. Janus magnetic 
spheroid structures do not exhibit the cytotoxic affects associated with MNP internalization 
common to dispersed and uptake methods by separating MNPs and cells into segregated 
and distinct regions. The combination of MNPs (black), cells (pink), and ECM (collagen, 
blue) into segregated regions decreases cellular toxicity related to MNPs by decreasing 
interactions with cells. 
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accelerate the degradation of iron oxide in cellular spheroids [77]. The optimal iron oxide 
MNP concentration, particle type, particle shape, polymer coating or functionalization 
will have to be determined moving forward for tissue engineering applications. One more 
limitation is how to address any potential unwanted activation of endothelial and smooth 
muscle cells by the particles.  
 
Promoting Active Contact Between Magnetic Cellular Spheroids Using Magnetic 
Forces 
 Conventional tissue assembly and fabrication methods include cell printing, cell 
sheet techniques, and patterned molds [11, 26, 29, 62]. These non-magnetic methods 
spatially orient the cells and tissues into a desired position through passive contact, but do 
not promote active contact for accelerated tissue fusion. Due to this, engineered tissues 
are not homogenous or cohesive and problems arise when handling the tissues. It is 
known that when two spheroids are placed into contact that they will fuse into a single 
cohesive tissue over time [34, 58, 71, 150]. Tissue fusion is a critical process for the 
development and maturation of tissues [34, 58, 150]. Here, magnetic forces were used to 
pattern, align and promote active contact between magnetic cellular spheroids in order to 
accelerate the tissue fusion process [37, 78]. Data has shown that when Janus spheroids 
are patterned into rings and exposed to magnetic forces, they fused into a homogenous 
and cohesive ring after 48 hours (Figure 5.2). Rings composed of spheroids without 
MNPs and magnetic forces showed minimal fusion and fell apart upon handling. This  
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technique is innovative because it focuses on using magnetic forces to actively promote 
fusion of novel magnetic cellular spheroids. 
 A limitation of using magnetic forces and MNPs to build larger tissues is the 
potential for the development of necrotic areas within the tissue. While the MNPs have 
been shown to have minimal toxic effects in individual spheroids, the viability of larger 
and more complex tissues decreases with size, due to diffusion limits. 
 
Spheroid Composition Influences Fusion 
 Spheroid composition is critical to the fusion process and manipulation of the 
composition was utilized to study fusion kinetics of JMCSs mediated by magnetic forces. 
Figure 5.2. Magnetic Forces Mediate the Fusion of JMCSs. Janus MNP and MNP-free 
control spheroids were each seeded into silicone ring molds and allowed to fuse for 48 
hours. JMCS ring molds were exposed to magnetic forces, while MNP-free control ring 
molds were not. Results showed that MNP-free control rings experienced minimal fusion, 
as individual spheroids were visible after 48 hours. Results demonstrated that, over 48 
hours, magnetic forces mediated the fusion of JMCSs into a fused tissue ring. Scale bars = 
1000 μm. 
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Results showed that ECM content and cell number play a key role in mediating the fusion 
of cellular spheroids into complex tissues (Figure 5.3). Results showed that iron oxide 
MNPs in JMCSs stimulate collagen production, which is critical for scaffold free tissue 
engineering. Further, results demonstrated that cell-cell and cell-ECM interactions in 
spheroids are critical in determining the fusion dynamics of tissues. This new 
understanding of JMCS composition and its influence on fusion can be applied to the 
fabrication of larger tissues, like blood vessels. This could be a change in paradigm when 
related to tissue engineering approaches because more collagen does not result in 
enhanced fusion.  
  
Figure 5.3. Varying Spheroid Composition Influences Ring Fusion Over Time. 
Visual analysis of ring fusion confirms that collagen content plays a significant 
role in tissue fusion and compaction, with decreases in fusion and compaction 
becoming evident with increasing collagen concentrations.  
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 A limitation of manipulating spheroid content (collagen and cell number) is that 
the influence will vary with the type or types of cells used. While this work demonstrates 
the effects of spheroid content on fusion and cell intermixing for primary rat aortic 
smooth muscle cells, endothelial and fibroblast cells would also have to be examined for 
vascular tissue engineering applications. 
 
Cyclic Longitudinal Stretching Using Magnetic Forces 
 Fabrication of functional tissue engineered constructs with appropriate cell 
densities, ECM contents, and mechanical properties that mimic native tissues still remain 
a challenge due to the lack of understanding associated with tissue fusion and maturation 
mechanisms [11, 58]. Cyclic radial stretching and pulsatile flow have been shown to 
enhance ECM production (collagen) and enhance mechanical properties, but the 
parameters for optimal maturation (frequency, magnitude, time of stimulation) have not 
been defined [56, 57, 82, 83, 85]. These studies overlook another force experienced by 
blood vessels, longitudinal stretch. Almost all arteries in vivo experience longitudinal 
strain (axial), with magnitudes ranging from 40% to 65% [162-164]. Studies have shown 
that static and cyclic longitudinal loading of tissue engineered constructs can accelerate 
extracellular matrix deposition and rapidly improve mechanical properties, both of which 
are critical for the development of a suitable tissue engineered replacements [81, 86]. 
Magnetic nanoparticles have been incorporated into cellular spheroids and aligned and 
patterned using magnetic force assembly [88, 90, 92, 93, 97, 151, 152], but the use of 
magnetic forces for accelerating maturation of vascular constructs has not been studied. 
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 Here, cyclic longitudinal stretching of tissues composed of Janus magnetic 
cellular spheroids (JMCSs) was mediated by magnetic forces and used as a post-
processing method for enhancing ECM deposition and mechanical properties (Figure 
5.4). First, we demonstrated that over 40 days, JMCSs will express collagen I, collagen 
IV, elastin and fibronectin, which are key vascular ECM proteins. Next, we showed that 
fused tissue sheets composed of JMCSs continue to produce these key proteins when 
exposed to magnetic forces. Quantitative results demonstrate that cyclic longitudinal 
stretching of the tissue sheets mediated by magnetic forces increases the Young’s 
modulus, enhances collagen production and induces collagen fiber alignment over 7 days, 
when compared to statically conditioned controls. These findings indicate that cyclic 
longitudinal stretching of tissues using magnetic forces has the potential to be used for 
maturation. 
 A limitation of this approach to magnetic maturation is the limited knowledge of 
what parameters lead to optimal tissue maturation. The most optimal frequency, 
magnitude, magnetic field strength and time of stimulation must be determined for each 
application and tissue type. One interesting thought to consider is: “how much tissue 
maturation is enough?” This question opens the door to many other questions moving 
forward. Do the mechanical properties have to be exactly the same as native tissue? Does 
the collagen content have to be less than, the same as, or more than native tissue? Will 
the body be able to play a role as bioreactor? Future in vitro studies, modeling and 
translation to animal models will help address these questions. 
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Concluding Remarks  
 Here, spheroid composition was manipulated, by varying ECM and cell contents, 
in order to study the resulting effects on JMCS fusion mediated by magnetic forces. Next, 
the influence of iron oxide MNPs on ECM production in JMCSs was studied over time. 
Further, magnetic sheets composed of JMCSs were fabricated and their maturation 
mediated by cyclic longitudinal stretching using magnetic forces. The objective of this 
work was to determine the mechanisms associated with the fusion and maturation of 
JMCSs and tissues composed of JMCSs. The hypotheses driving this work were that 
Figure 5.4. Processing and Post-Processing of Tissues Using Magnetic Forces. 
Magnetic templates were used to pattern spheroids into sheets and mediate their fusion with 
enhanced contacts. After 10 days, an actuator was used to induce cyclic uniaxial 
longitudinal stretch on the MNP containing sheets. Our results demonstrated increased 
mechanical properties, enhanced protein content and ECM alignment. 
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spheroid composition dictates their fusion and that magnetic forces can be utilized to 
dynamically condition tissues composed of JMCSs for maturation. 
 Results demonstrated the critical importance of magnetic forces for promoting the 
fusion of JMCSs, when compared to JMCSs not exposed to magnetic forces. Further, 
results demonstrate the critical role of cell-cell and cell-ECM interactions for mediating 
cellular spheroid fusion over time. Results showed that the addition of iron oxide 
magnetic nanoparticles in JMCSs caused a significant increase in collagen production, 
when compared to no iron oxide controls. Quantitative results demonstrate that cyclic 
longitudinal stretching of tissue sheets mediated by magnetic forces increases the 
Young’s modulus, enhances ECM production and induces collagen fiber alignment over 
7 days, when compared to statically conditioned controls.  
 This project focused on understanding the fusion and maturation of Janus 
magnetic cellular spheroids mediated by magnetic forces. These findings are expected to 
provide a strong theoretical and methodological foundation for the development of new 
tissue engineering technologies. While this project is still new, there is a lot of potential 
for further exploration and experimentation to learn more about these mini-tissues and 
their applications. 
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CHAPTER 6 
FUTURE RECOMMENDATIONS 
 Based on the literature review and research presented in this document, future 
recommendations are described below:  
 
6.1 Determining Optimal Spheroid Composition for Building Tissues 
 The work presented in this thesis has a focus in understanding the influences of 
collagen content and cell density on fusing magnetic cellular spheroids over time. For the 
spheroids used in this work, the collagen had been added during the fabrication process 
and enhanced spheroid formation over the course of three days. Through this work, we 
found that low collagen contents and high cell densities promoted the most fusion and 
cellular intermixing between adjacent spheroids over time when mediated by magnetic 
forces [37]. However, initial work in our lab has shown that building tubular tissues with 
magnetic cellular spheroids required higher collagen contents to fabricate a structure that 
could stand alone without collapsing on itself, when compared to low collagen contents 
[78]. Other groups have shown that using just cells and the endogenous extracellular 
matrix that they produce is sufficient to produce tissues with measurable mechanical 
properties [53, 54]. Using human aortic smooth muscle cells, Gwyther generated tissue 
rings, which formed after 24 hours, and was able to place them into contact on a silicon 
mandrel to form a tubular tissue [53, 54]. However, even after 7 days, ring margins were 
still visible, indicating more time is required for complete fusion. 
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 To improve upon the work in our lab for building vascular tissues using cellular 
spheroids, the following is recommended. Janus magnetic cellular spheroids should be 
fabricated with just cells and iron oxide magnetic nanoparticles. Our work has shown that 
the spheroids will produce their own collagen over time, with more than double the 
collagen content after 20 days and more than 6 times the collagen content after 40 days. 
The addition of exogenous matrix should be eliminated because many groups already 
fabricate spheroids without it. While we have shown the collagen production over time in 
individual spheroids, it would be interesting to see how much collagen is produced in 
larger tissues composed of spheroids over time. Due to cell adhesion, cell intermixing 
and signaling through cytokines, it can be expected more collagen is produced in tissues 
composed of spheroids when compared to individual spheroids over time. 
 Additionally, it is recommended that attempts are made to pattern spheroids after 
a day of formation. Currently, spheroids in our lab are left to form in a hanging drop for 
three days to achieve the desired spherical shape. Work has been shown by Morgan and 
coworkers that pre-cultured spheroids (1, 4 and 7 days), which are more mature, fuse 
more slowly over time when compared to spheroids that were not pre-cultured prior to 
being placed into contact [185]. Based on this work, it seems that the faster the forming 
spheroids are placed into contact, the more quickly they will fuse into a cohesive and 
homogenous structure. For example, if tissue sheets are desired for tube fabrication, 
spheroids should be formed for 24 hours in the hanging drop, then seeded onto a 
magnetic template to fuse into a sheet for 24 hours and then wrapped around a mandrel to 
form a tube. This technique will ensure the most rapid fusion and minimize tissue gaps.  
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6.2 Elastin Synthesis in Spheroids Over Time 
 While a focus of this thesis was on quantifying collagen content in spheroids over 
time, another important extracellular matrix protein for vascular tissues is elastin. Elastin 
is distensible and provides elasticity to distribute stress throughout vessel walls and 
collagen fibers. Inducing in vitro production of elastin in tissue engineered constructs will 
be critical to fabricating tissues that mimic native tissues and is considered the holy grail 
of tissue engineering. Our lab has been investigating the use of ascorbic acid (50 µg/mL) 
on collagen production in individual spheroids and we have seen that it does in fact 
induce collagen synthesis over 40 days when compared to spheroids without ascorbic 
acid treatment [37]. Histological examination using immunohistochemistry has shown 
increases in positive expression of elastin over time in spheroids with ascorbic acid 
treatment, when compared to no treatment. Even more, there seems to be a synergistic 
effect between ascorbic acid and iron oxide magnetic nanoparticles for the production of 
elastin.  
 In 2013, a study by Derricks and coworkers observed a dramatic increase in 
elastin production from primary rat neonatal pulmonary fibroblasts in response to 
ascorbic acid in 3D cell-Gelfoam constructs [174]. From day 14 to 21, ELISA results 
showed that elastin deposition increased 4.5 fold in the ascorbic acid treated 3D cell-
Gelfoam constructs when compared to no ascorbic acid treated tissues [174]. q-PCR 
results supported these results as protein expression increased from 1.5 fold to 8.8 fold 
over the same time period for ascorbic acid treated tissues [174]. At the same time, no 
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significant elastin deposition was observed in 2D cultures of the same cell type over time 
[174]. These results indicate that the 3D nature of the cell-ECM environment will direct 
the cellular response to ascorbic acid. While ascorbic acid has not been shown to 
significantly induce elastin production in 2D cultures of smooth muscle cells, here we 
have shown that cellular spheroids, which are 3D cell cultures, will respond to treatment 
with ascorbic acid (50 μg/mL). Based on work by Derricks and coworkers, we can 
attribute the cellular response in the spheroids from ascorbic acid to the 3D architecture 
of the spheroids. Future work should include quantification of elastin production over 
time in individual spheroids and tissues composed of spheroids. Even more, the influence 
of ascorbic acid on elastin production must be examined. 
  
6.3 Magnetic Bioprinting of Magnetic Cellular Spheroids 
 Mechanical testing is critical for predicting the success of tissue engineering 
vasculature for handling the forces experienced in vivo. The battery of tests for vascular 
tissues includes burst pressure testing, compliance testing and suture retention strength 
testing. To be able to perform these tests, the tissue construct to be test must meet 
minimum size requirements (length and diameter) in order to fit into the respective 
testing devices. To fabricate a tissue tube composed of Janus magnetic cellular spheroids 
of relevant size, it requires at least 8,000 spheroids. This translates to 160 million cells, 7-
8 hours of lab work with three students and a lot of consumables used. If there are no 
setbacks or errors, this will yield one tube. For statistically significant data, three tubes 
would be required, so a means to upscale and automate is necessary.  
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 To address this a magnetic bioprinter should be designed and fabricated with a 
robotic arm that has a magnet on the end, which will have the ability to attract a 
cell/MNP solution or spheroids with the magnetic field ‘on’ and be able to move the arm 
in the X, Y and Z planes to accurately place the spheroid and print it by simply turning 
‘off’ the field. The printer could be used to dispense a cell/MNP solution to fabricate 
spheroids or dispense preformed spheroids into desired positions with high precision and 
accuracy. Being able to load a cell/MNP solution or spheroids into a bioprinter will allow 
for more spheroids or constructs to be produced in a given amount of time due to the 
automation. Further, automation will reduce risk of human error and contamination.  
 Whatley and coworkers used a homemade bioprinter to dispense controlled 
amounts of endothelial cells loaded with iron oxide magnetic nanoparticles into agarose 
molds using magnetic forces [68]. After three days of formation, spheroids were shown 
to viable and could be patterned on predefined magnetic templates [68]. Perhaps this 
concept can be translated to dispense cell solutions with iron oxide magnetic 
nanoparticles into hanging drops on petri dishes guided by magnetic forces. 
 Souza and coworkers developed a vascular ring assay for smooth muscle 
contractility using magnetic 3D bioprinting [186]. Magnetically labeled cells were 
magnetically printed into rings in 96 well plates, which then contracted or dilated over 
time under a battery of vasodilators. This technology represents a rapid and robust in 
vitro assay that mimics native 3D tissue and allows for high throughput analysis. 
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6.4 Using Janus Magnetic Cellular Spheroids for High Throughput Drug Screening 
 While building tissues and organs represents an exciting application of cellular 
spheroids, the technology is also applicable to other areas of science. Pharmaceutical 
companies have been actively partnering with bioprinting groups to fabricate micro-
tissues that can be used for high throughput screening of drugs. For example, Roche has 
partnered with Organovo to develop model kidney and liver model tissues for the 
screening process [66]. Organovo recently launched the exVive3D liver tissue test kit and 
intends to use it to provide better predictors of liver toxicity earlier in the research 
pipeline. Souza and coworkers have partnered with the Houston Methodist Research 
Institute and reported the use of a magnetic levitation high throughput system to 
biofabricate tumor models for cancer research [67]. Clearly, pharmaceutical companies 
are interested in the high throughput potential of spheroids and mini-tissues because it 
can more accurately mimic the native environment when compared to 2D models. Of 
course, the technology can save pharmaceutical companies a lot of money for in vitro 
testing and can even potentially reduce animal and human trials if human cells are used. 
 Our lab has fabricated cellular spheroids with and without magnetic nanoparticles 
that maintain viability through 7 weeks [78]. We also possess the capability to culture 
hundreds of spheroids at a time using 96 well plates. Future work should include testing 
individual spheroids and rings composed of spheroids with a variety of vasodilators 
(blebbistatin, forskolin, and verapamil) and vasoconstrictors (norepinephrine, 
phenylephrine and U46619) and compare to values for native tissues. Here, individual 
cell types or co-culture tissues can be fabricated and tested using the high throughput 
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system. This type of testing can give an indication of functionality of the formed 
spheroids over time to see if it can compare to native tissues. 
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